This invention relates to personal vapor inhaling units and more particularly to an atomizer/vaporizer of an electronic flameless vapor inhaler unit that may simulate a cigarette or deliver nicotine and other medications to the oral mucosa, pharyngeal mucosa, tracheal, and pulmonary membranes.
An alternative to smoked tobacco products, such as cigarettes, cigars, or pipes is a personal vaporizer Inhaled doses of heated and atomized flavor, which provides a physical sensation similar to smoking. However, because a personal vaporizer is typically electrically powered, no tobacco, smoke, or combustion is usually involved in its operation. For portability, and to simulate the physical characteristics of a cigarette, cigar, or pipe, a personal vaporizer may be battery powered. In addition, a personal vaporizer may be loaded with a nicotine bearing substance and/or a medication bearing substance. The personal vaporizer may provide an inhaled dose of nicotine and/or medication by way of the heated and atomized substance. Thus, personal vaporizers may also be known as electronic cigarettes, or e-cigarettes. Personal vaporizers may be used to administer flavors, medicines, drugs, or substances that are vaporized and then inhaled.
In an embodiment, a personal vaporizer unit comprises a mouthpiece configured for contact with the mouth of a person. At least part of this mouthpiece has an antimicrobial surface. This mouthpiece may also comprise silicone rubber, thermoplastic elastomer, organosilane, silver impregnated polymer, silver impregnated thermoplastic elastomer, and/or polymer. The mouthpiece may be removed from the personal vaporizer for washing or replacement, without using a tool. The mouthpiece may be provided in different colors. Designs or other patterns may be visible on the outside of the mouthpiece.
In an embodiment, a personal vaporizer unit comprises a first conductive surface configured to contact a first body part of a person holding the personal vaporizer unit, and a second conductive surface, conductively isolated from the first conductive surface, configured to contact a second body part of the person. When the personal vaporizer unit detects a change in conductivity between the first conductive surface and the second conductive surface, the vaporizer is activated to vaporize a substance so that the vapors may be inhaled by the person holding the vaporizer unit. The first body part and the second body part may be a lip or parts of a hand(s). The two conductive surfaces may also be used to charge a battery contained in the personal vaporizer unit. The two conductive surfaces may also form, or be part of, a connector that may be used to output data stored in a memory.
In an embodiment, a personal vaporizer unit comprises a chamber configured to receive a cartridge. The cartridge may hold a substance to be vaporized. The chamber may be configured at the distal end of the personal vaporizer unit. A user may inhale the vaporized substance at the proximal end of the personal vaporizer unit. At least one space between the exterior surface of the cartridge and an interior surface of the chamber may define a passage for air to be drawn from outside the personal vaporizer unit, near the distal end, through the personal vaporizer unit to be inhaled by the user along with the vaporized substance. The personal vaporizer unit may also include a puncturing element that breaks a seal on the cartridge to allow a substance in the cartridge to be vaporized. An end surface of the cartridge may be translucent to diffuse light produced internally to the personal vaporizer unit. The translucent end may be etched or embossed with letters, symbols, or other indicia that are illuminated by the light produced internally to the personal vaporizer unit.
In an embodiment, a personal vaporizer unit comprises a first wick element and a second wick element having a porous ceramic. The first wick element is adapted to directly contact a liquid held in a reservoir. The reservoir may be contained by a cartridge that is removable from the personal vaporizer unit. A heating element is disposed through the second wick element. An air gap is defined between the first wick element and the second wick element with the heating element exposed to the air gap. Air enters the first wick element through a hole in a housing holding the first wick element.
In an embodiment, a personal vaporizer unit comprises a light source internal to an opaque cylindrical housing that approximates the appearance of a smoking article. A cylindrical light tube is disposed inside the opaque cylindrical housing to conduct light emitted by the light source to an end of the opaque cylindrical housing. This allows the light to be visible outside of the opaque cylindrical housing of the vaporizer.
In an embodiment, a personal vaporizer unit comprises a microprocessor, a memory, and a connector. The connector outputs data stored in the memory. The microprocessor may gather, and store in the memory, information including, but not limited to, the number of cycles the device has been triggered, the duration of the cycles, the number of cartridges of fluid that are delivered. The microprocessor may also gather and store times and dates associated with other information gathered and stored. The microprocessor may detect an empty cartridge by detecting a specific change in resistance between a wick and a housing that is equivalent to a “dry wick,” and thus signifies an empty cartridge.
In an embodiment, a case comprises a cradle adapted to hold a personal vaporizer unit. The personal vaporizer unit has dimensions approximating a smoking article. The case includes a battery and at least two contacts. The two contacts may form an electrical contact with the personal vaporizer unit when the personal vaporizer unit is in the cradle. The two contacts may conduct charge from the battery to the personal vaporizer unit to charge the personal vaporizer unit. The case may also download and store data retrieved from the personal vaporizer unit. The case may download and store this data via the at least two contacts. The case may send this data to a computer via wired or wireless links. The case may have more than one cradle and sets of contacts (e.g., two sets of two contacts in order to hold and charge two personal vaporizer units).
In an embodiment, personal vaporizer unit 100 is configured such that outer main shell 102 comprises a first conductive surface configured to contact a first body part of a person holding personal vaporizer unit 100. Mouthpiece 116 comprises a second conductive surface, which is conductively isolated from the first conductive surface. This second conductive surface is configured to contact a second body part of the person. When personal vaporizer unit 100 detects a change in conductivity between the first conductive surface and the second conductive surface, a vaporizer internal to personal vaporizer unit 100 is activated to vaporize a substance in cartridge 150 so that the vapors may be inhaled by the person holding personal vaporizer unit 100. The first body part and the second body part may be a lip or parts of a hand(s). The two conductive surfaces of outer main shell 102 and mouthpiece 116, respectively, may also be used to charge battery 104 contained in the personal vaporizer unit 100. The two conductive surfaces of outer main shell 102 and mouthpiece 116, respectively, may also be used to output (or input) data stored (or to be stored) in a memory (not shown).
Battery support 106 functions to hold battery 104 in a position which is fixed relative to outer main shell 102. Battery support 106 is also configured to allow air and vaporized substance to pass from the distal end of personal vaporizer unit 100 past battery 104 along one or more passageways. After air and the vapors of the vaporized substance pass by battery 104, they may pass through openings in mouthpiece 116, mouthpiece cover 114, and mouthpiece insulator 112, to be inhaled by a user.
In
Atomizer housing 132 (and therefore proximal wick 136, distal wick 134) are disposed inside light pipe sleeve 140 and outer main shell 102. (Note: for clarity, outer main shell 102 is not shown in
Cartridge 150 is disposed within light pipe sleeve 140. When assembled, a substance contained within cartridge 150 is held in direct contact with distal wick 134. When cartridge 150 is inserted into personal vaporizer unit 100 atomizer housing 132 or distal wick 134 may puncture a seal or cap that contains the substance to be vaporized within cartridge 150. Once punctured, the substance held within a reservoir of cartridge 150 may come in direct contact with distal wick 134.
For example, a first conductive surface on mouthpiece 116 may be configured to contact a first body part of a person holding personal vaporizer unit 100. A second conductive surface on outer main shell 102 (which is conductively isolated from said first conductive surface by mouthpiece insulator 112) may be configured to contact a second body part of the person. Personal vaporizer unit 100 may then activate in response to detecting a change in conductivity between the first conductive surface and the second conductive surface. In an embodiment, this change in conductivity may comprise a drop in impedance between the first conductive surface and the second conductive surface. In an embodiment, the change in conductivity may comprise a change in capacitance between the first conductive surface and the second conductive surface. The first body part may be a finger. The second body part may be a lip. The second body part may be a second finger. In an embodiment, the first conductive surface and the second conductive surface may be used to pass a charging current to battery 104. The first and second conductive surfaces may also be used to transfer data to or from personal vaporizer unit 100.
Main housing 160 also has a hole 165 that allows an electrical conductor (not shown) to run from PC-board 123 or PC-board 124 through main housing 160. This electrical conductor may be, or connect to, a heating element (not shown). This heating element may help vaporize the substance to be inhaled by the user of personal vaporizer unit 100. This heating element may be controlled by circuitry on PC-board 123 or PC-board 124. This heating element may be activated in response to a change in conductivity between the first conductive surface and the second conductive surface, described previously.
The exterior of main housing 160 may also have a flat surface 164 (or other geometry) forming a galley that is configured to allow the vaporized substance and air to pass between the main housing 160 and the outer main shell 102. Once the vaporized substance and air pass by main housing 160, they may travel through passageway 112-1, passageway 116-1, and opening 114-1 to be inhaled by a user of personal vaporizer unit 100. The exterior of main housing 160 may also have one or more standoffs 167 (or other geometries) that are configured to allow air and the vaporized substance to reach the passageway formed by flat surface 164 and outer main shell 102.
Main housing 260 is configured to hold PC-boards 123 and 124, and spacer 128. Main housing 260 is configured to fit within outer main shell 102 via a friction fit. Main housing 260 has several holes 266 that allow light generated by a light source(s) on PC-board 124 to pass. Once this light passes through holes 266, it may be coupled into light pipe sleeve 140 where it is conducted to a visible location on the outside of personal vaporizer unit 100.
Main housing 260 also has a hole 265 that allows an electrical conductor (not shown) to run from PC-board 123 or PC-board 124 through main housing 260. This electrical conductor may be, or connect to, a heating element (not shown). This heating element may help vaporize the substance to be inhaled by the user of personal vaporizer unit 100. This heating element may be controlled by circuitry on PC-board 123 or PC-board 124. This heating element may be activated in response to a change in conductivity between the first conductive surface and the second conductive surface, described previously.
The exterior of main housing 260 may also have flat surfaces 264 (or other geometry) that form a galley that is configured to allow the vaporized substance and air to pass between the main housing 260 and the outer main shell 102. Once the vaporized substance and air pass by main housing 260, they may travel through passageway 112-1, passageway 116-1, and opening 114-1 to be inhaled by a user of personal vaporizer unit 100. The exterior of main housing 260 may also have one or more standoffs 267 (or other geometries) that are configured to allow air and the vaporized substance to reach the passageway formed by flat surfaces 264 and outer main shell 102.
PC-board 123 may have mounted on it a microprocessor, memory, or other circuitry (not shown) to activate or otherwise control personal vaporizer unit 100. This microprocessor may store data about the operation of personal vaporizer unit 100 in the memory. For example, the microprocessor may determine and store the number of cycles personal vaporizer unit 100 has been triggered. The microprocessor may also store a time and/or date associated with one or more of these cycles. The microprocessor may cause this data to be output via a connector. The connector may be comprised of the first and second conductive surfaces of mouthpiece 116 and/or outer main shell 102.
In an embodiment, the microprocessor may determine a duration associated with various cycles where personal vaporizer unit 100 has been triggered. These durations (or a number based on these durations, such as an average) may be stored in the memory. The microprocessor may cause these numbers to be output via the connector. The microprocessor may determine an empty cartridge condition and store a number associated with a number of times said empty cartridge condition occurs. The microprocessor, or other circuitry, may determine an empty cartridge condition based on a resistance between atomizer housing 132 or 232 and a wick 134, 234, 136, or 236. The microprocessor may also store a time and/or date associated with one or more of these empty cartridge conditions. The number of times an empty cartridge condition is detected, times, and/or dates associated with these empty cartridge conditions may be output via the connector.
Battery 104, PC-board 123, PC-board 124, and all electronics internal to personal vaporizer unit 100 may be sealed in a plastic or plastic and epoxy compartment within the device. This compartment may include main housing 160 or 260. All penetrations in this compartment may be sealed. Thus, only wires will protrude from the compartment. The compartment may be filled with epoxy after the assembly of battery 104, PC-board 123, PC-board 124, and LEDs 125-127. The compartment may be ultrasonically welded closed after assembly of battery 104, PC-board 123, PC-board 124, and LEDs 125-127. This sealed compartment is configured such that all vapor within personal vaporizer unit 100 does not come in contact with the electronics on PC-boards 123, 124.
Chamfered surface 132-3 has one or more holes 132-1. These holes allow air to pass, via suction, through atomizer housing 132 into distal wick 134. This suction may be supplied by the user of personal vaporizer unit 100 sucking or inhaling on mouthpiece cover 114 and/or mouthpiece 116. The air that is sucked into distal wick 134 enters distal wick 134 on or near the chamfered surface between the two cylinders of distal wick 134. The air that is sucked into distal wick 134 displaces some of the substance being vaporized that has been absorbed by distal wick 134 causing it to be atomized as it exits distal wick 134 into the air gap formed between distal wick 134 and proximal wick 136. The heating element disposed around proximal wick 136 may then vaporize at least some of the atomized substance. In an embodiment, one or more holes 132-1 may range in diameter between 0.02 and 0.0625 inches.
In an embodiment, placing holes 132-1 at the leading edge of the chamfered surface places a set volume of the substance to be vaporized in the path of incoming air. This incoming air has nowhere to go but through the large diameter (or “head”) end of the distal wick 134. When the air enters this area in distal wick 134 it displaces the substance to be vaporized that is suspended in distal wick 134 towards an air cavity between distal wick 134 and proximal wick 136. When the displaced substance to be vaporized reaches the surface of distal wick 134, it is forced out of the wick by the incoming air and the negative pressure of the cavity. This produces an atomized cloud of the substance to be vaporized. In an embodiment, the diameter of the head end of the distal wick 134 may be varied and be smaller than the diameter of the proximal wick 136. This allows for a tuned volume of air to bypass proximal wick 136 and directly enter the cavity between distal wick 134 and proximal wick 136 without first passing through proximal wick 136.
Chamfered surface 232-3 has one or more holes 232-1. These holes allow air to pass, via suction, through atomizer housing 232 into distal wick 234. The air that is sucked into distal wick 234 enters distal wick 234 on or near the chamfered surface between the two cylinders of distal wick 234. The air that is sucked into distal wick 234 displaces some of the substance being vaporized that has been absorbed by distal wick 234 causing it to be atomized as it exits distal wick 234 into the air gap formed between distal wick 234 and proximal wick 136. The heating element disposed around proximal wick 136 may then vaporize at least some of the atomized substance being vaporized. In an embodiment, one or more holes 232-1 may range in diameter between 0.02 and 0.0625 inches.
In an embodiment, placing holes 232-1 at the leading edge of the chamfered surface places a set volume of the substance to be vaporized in the path of incoming air. This incoming air has nowhere to go but through the head end of the distal wick 234. When the air enters this area in distal wick 234 it displaces the substance to be vaporized that is suspended in distal wick 234 towards an air cavity between distal wick 234 and proximal wick 236. When the displaced substance to be vaporized reaches the surface of distal wick 234, it is forced out of the wick by the incoming air and the negative pressure of the cavity. This produces an atomized cloud of the substance to be vaporized. In an embodiment, the diameter of the head end of distal wick 234 may be varied and be smaller than the diameter of the proximal wick 236. This allows for a tuned volume of air to bypass proximal wick 236 and directly enter the cavity between distal wick 234 and proximal wick 236 without first passing through proximal wick 236.
In an embodiment, distal wicks 134, 234, and proximal wicks 136, 236, may be made of, or comprise, for example a porous ceramic. Distal wicks 134, 234, and proximal wicks 136, 236, may be made of, or comprise aluminum oxide, silicon carbide, magnesia partial stabilized zirconia, yttria tetragonal zirconia polycrystal, porous metal (e.g., steel, aluminum, platinum, titanium, and the like), ceramic coated porous metal, woven metal, spun metal, metal wool (e.g., steel wool), porous polymer, porous coated polymer, porous silica (i.e., glass), and/or porous Pyrex. Distal wicks 134, 234, and proximal wicks 136, 236, may be made of or comprise other materials that can absorb a substance to be vaporized.
The conductor or heating element that is disposed through proximal wick 136 or 236 may be made of, or comprise, for example: nickel chromium, iron chromium aluminum, stainless steel, gold, platinum, tungsten molybdenum, or a piezoelectric material. The conductor or heating element that is disposed through proximal wick 136 or 236 can be made of, or comprise, other materials that become heated when an electrical current is passed through them.
The hollow portion of cartridge 150 is configured as a reservoir to hold the substance to be vaporized by personal vaporizer unit 100. The hollow portion of cartridge 150 holds the substance to be vaporized in direct contact with distal wick 134 or 234. This allows distal wick 134 or 234 to become saturated with the substance to be vaporized. The area of distal wick 134 or 234 that is in direct contact with the substance to be vaporized may be varied in order to deliver different doses of the substance to be vaporized. For example, cartridges 150 with differing diameter hollow portions may be used to deliver different doses of the substance to be vaporized to the user.
Cartridge 150 may be configured to confine the substance to be vaporized by a cap or seal (not shown) on the proximal end. This cap or seal may be punctured by the end of atomizer housing 132, or the pointed end 234-1 of distal wick 234.
When inserted into personal vaporizer unit 100, cartridge standoffs 157 define an air passage between the end of light pipe sleeve 140 and outer main shell 102. This air passage allows air to reach the air passage defined by flat surface 158.
The hollow portion of cartridge 150 also includes one or more channels 154. The end of these channels are exposed to air received via the air passage(s) defined by flat surface 158. These channels allow air to enter the hollow portion of cartridge 150 as the substance contained in cartridge 150 is drawn into a distal wick 134 or 234. Allowing air to enter the hollow portion of cartridge 150 as the substance contained in cartridge 150 is removed prevents a vacuum from forming inside cartridge 150. This vacuum could prevent the substance contained in cartridge 150 from being absorbed into distal wick 134 or 234.
In an embodiment, cartridge 150 may be at least partly translucent. Thus cartridge 150 may act as a light diffuser so that light emitted by one or more of LEDs 125-127 is visible external to personal vaporizer unit 100.
Personal vaporizer case 500 includes a battery that may hold charge that is used to recharge a personal vaporizer unit 100. Recharging of personal vaporizer unit 100 may be managed by a charge controller that is part of case 500.
When case 500 is holding a personal vaporizer unit 100, at least a portion of the personal vaporizer unit 100 is visible from the outside of case 500 to allow a light emitted by personal vaporizer unit 100 to provide a visual indication of a state of personal vaporizer unit 100. This visual indication is visible outside of case 500.
Personal vaporizer unit 100 is activated by a change in impedance between two conductive surfaces. In an embodiment, these two conductive surfaces are part of outer main shell 102 and mouthpiece 116. These two conductive surfaces may also be used by case 500 to charge battery 104. These two conductive surfaces may also be used by case 500 to read data out of personal vaporizer unit 100.
In an embodiment, when a user puts personal vaporizer unit 100 in his/her mouth and provides “suction,” air is drawn into personal vaporizer unit 100 though a gap between the end of outer main shell 102 and cartridge 150. In an embodiment, this gap is established by standoffs 157. Air travels down galley(s) formed by flat surface(s) 158 and the inner surface of light pipe sleeve 140. The air then reaches a “ring” shaped galley between atomizer housing 132, cartridge 150, and light pipe sleeve 140. Air travels to distal wick 134 via one or more holes 132-1, in chamfered surface(s) 132-3. Air travels to distal wick 234 via one or more holes 232-1, in chamfered surface(s) 232-3. Air is also allowed to enter cartridge 150 via one or more channels 154. This air entering cartridge 150 via channels 154 “back fills” for the substance being vaporized which enters distal wick 134. The substance being vaporized is held in direct contact with distal wick 134 or 234 by cartridge 150. The substance being vaporized is absorbed by and may saturate distal wick 134 or 234 and proximal wick 136 or 236.
The incoming air drawn through holes 132-1 displaces from saturated distal wick 134 the substance being vaporized. The displaced substance being vaporized is pulled from distal wick element 134 into a cavity between distal wick 134 and proximal wick 136. This cavity may also contain a heating element that has been heated to between 150-200° C. The displaced substance being vaporized is pulled from distal wick element 134 in small (e.g., atomized) droplets. These atomized droplets are vaporized by the heating element.
In an embodiment, when a user puts personal vaporizer unit 100 in his/her mouth and provides “suction,” air is drawn into personal vaporizer unit 100 though a gap between the end of outer main shell 102 and cartridge 150. In an embodiment, this gap is established by standoffs 157. Air travels down galley(s) formed by flat surface(s) 158 and the inner surface of light pipe sleeve 140. The air then reaches a “ring” shaped galley between atomizer housing 232, cartridge 150, and light pipe sleeve 140. Air travels to distal wick 234 via one or more holes 232-1, in chamfered surface(s) 232-3. Air is also allowed to enter cartridge 150 via one or more channels 154. This air entering cartridge 150 via channels 154 “back fills” for the substance being vaporized which enters distal wick 234. The substance being vaporized is held in direct contact with distal wick 234 by cartridge 150. The substance being vaporized is absorbed by and may saturate distal wick 234 and proximal wick 236.
The incoming air drawn through holes 232-1 displaces from saturated distal wick 234 the substance being vaporized. The displaced substance being vaporized is pulled from distal wick 234 into a cavity between distal wick 234 and proximal wick 236. This cavity may also contain a heating element that has been heated to between 150-200° C. The displaced substance being vaporized is pulled from distal wick 234 in small (e.g., atomized) droplets. These atomized droplets are vaporized by the heating element.
In both of the previous two embodiments, the vaporized substance and air are drawn down a galley adjacent to battery 104, through mouthpiece insulator 112, mouthpiece 116, and mouthpiece cover 114. After exiting personal vaporizer unit 100, the vapors may be inhaled by a user.
The systems, controller, and functions described above may be implemented with or executed by one or more computer systems. The methods described above may be stored on a computer readable medium. Personal vaporizer unit 100, case 500, system 10800 (
Communication interface 620 may comprise a network interface, modem, port, bus, link, transceiver, or other communication device. Communication interface 620 may be distributed among multiple communication devices. Processing system 630 may comprise a microprocessor, microcontroller, logic circuit, or other processing device. Processing system 630 may be distributed among multiple processing devices. User interface 660 may comprise a keyboard, mouse, voice recognition interface, microphone and speakers, graphical display, touch screen, or other type of user interface device. User interface 660 may be distributed among multiple interface devices. Storage system 640 may comprise a disk, tape, integrated circuit, RAM, ROM, network storage, server, or other memory function. Storage system 640 may be a computer readable medium. Storage system 640 may be distributed among multiple memory devices.
Processing system 630 retrieves and executes software 650 from storage system 640. Processing system may retrieve and store data 670. Processing system may also retrieve and store data via communication interface 620. Processing system 630 may create or modify software 650 or data 670 to achieve a tangible result. Processing system 630 may control communication interface 620 or user interface 660 to achieve a tangible result. Processing system 630 may retrieve and execute remotely stored software via communication interface 620.
Software 650 and remotely stored software may comprise an operating system, utilities, drivers, networking software, and other software typically executed by a computer system. Software 650 may comprise an application program, applet, firmware, or other form of machine-readable processing instructions typically executed by a computer system. When executed by processing system 630, software 650 or remotely stored software may direct computer system 600 to operate as described herein.
In particular,
A battery carrier sleeve 76008 may be slidably coupled with the housing 76002 for guiding alternative movement of the battery carrier sleeve 76008 between an extended position and a retracted position. The vaporizer 76000 may be electrically activated to produce vapor when the battery carrier sleeve 76008 is moved into the extended position. Vapor production may be suspended, and the vaporizer 76000 may be temporarily deactivated, when the battery carrier sleeve 76008 is moved into the retracted position.
The battery carrier sleeve 76008 may be disposed within the housing 76002.
The housing 76002 may have an aperture 76010 extending into the housing 76002 and arranged adjacent to a surface of the battery carrier sleeve 76008. The surface of the battery carrier sleeve 76008 may be arranged so as to be manually accessible through the aperture 76010 by a user for controlling the movement of battery carrier sleeve 76008 between the retracted position and the extended position.
Battery 76042 may have at least one battery terminal. Battery 76042 may have a positive polarity battery terminal 76044 at one extremity of the battery 76042. Battery 76042 may have a negative polarity battery terminal 76046 at opposing extremity of the battery 76042. Battery carrier sleeve 76008 may be slidably coupled with housing sleeve 76048. The surface of the battery carrier sleeve 76008 may be arranged so as to be manually accessible through aperture 76010 by a user for controlling the movement of battery carrier sleeve 76008 between the retracted position and the extended position.
It should be understood that the invention is not limited to the battery polarity arrangement just discussed and shown in exploded view in
As shown in the exploded view of
The oral aspiration tube 76004 discussed previously herein may be fluidly coupled with the atomizer assembly 76050 for transporting vapor from the atomizer assembly 76050 to the user's mouth. When electrically activated, atomizer assembly 76050 can change liquid into vapor. Absorptive ceramic reservoir 76024 may provide for volume storage of the liquid. For example, the liquid may comprise a miscible liquid, and the absorptive ceramic reservoir 76024 may be adapted for volume storage of the miscible liquid.
Absorptive ceramic reservoir 76024 may be fluidly coupled with the atomizer assembly 76050 for providing the liquid to the atomizer assembly 76050, in response to aspiration by the user. In particular, air intake ports 76006 may extend through outer reservoir cover 76022, and may be fluidly coupled with the absorptive ceramic reservoir 76024 for bubbling air into the absorptive ceramic reservoir 76024 in response to aspiration by the user.
A first set of liquid transport apertures 76026A may extend through supportive inner reservoir sleeve 76025, for transporting liquid aspirated from the absorptive ceramic reservoir 76024 through the supportive inner reservoir sleeve 76025. Similarly, a second set of liquid transport apertures 76026B may extend through supportive atomizer fluid interface 76027, for transporting liquid aspirated from the absorptive ceramic reservoir 76024 through the supportive atomizer fluid interface 76027. Similarly, a third set of liquid transport apertures 76026C may extend into atomizer assembly 76050, for transporting liquid aspirated from the absorptive ceramic reservoir 76024 into atomizer assembly 76050.
In other words, the first and second sets of liquid transport apertures 76026A, 76026B may form at least one liquid aspiration channel 76026A, 76026B, which may be fluidly coupled between the atomizer assembly 76050 and the absorptive ceramic reservoir 76024 for aspirating the liquid from the absorptive ceramic reservoir 76024 in response to aspiration by the user. As shown in exploded view in
As shown in
As shown in
To provide for some user convenience, and to avoid an excessive need to refill the absorptive ceramic reservoir 76024 continually, the absorptive ceramic reservoir 76024 may have liquid absorption volume of greater than approximately half a milliliter. In particularly, the absorptive ceramic reservoir 76024 may have a liquid absorption volume sufficient for more than approximately seventy-five full aspiration cycles through the user's mouth and substantially filling a user's lungs. To provide for some user convenience and some compactness of the absorptive ceramic reservoir 76024, the absorptive ceramic reservoir 76024 may have liquid absorption volume less than approximately ten milliliters. Accordingly, the absorptive ceramic reservoir 76024 may have a liquid absorption volume within a range from approximately half a milliliter to approximately ten milliliters.
The absorptive ceramic reservoir 76024 may comprise a macroporous ceramic.
The macroporous ceramic may be substantially hydrophilic. Further, the macroporous ceramic may comprise a substantially open pore structured ceramic. Moreover, the macroporous ceramic may comprise a substantially interconnected macroporous ceramic.
The macroporous ceramic may comprise an oxide ceramic. More particularly, the macroporous ceramic may comprise Aluminum Oxide. Since the atomizer assembly 76050 may generate heat, to provide for some user safety the absorptive ceramic reservoir 76024 may be substantially a non-flammable. To provide for some safety of the user inhaling vapors of the vaporizer, the absorptive ceramic reservoir 76024 may be substantially chemically inert.
Parameters of the macroporous ceramic may be chosen so as to provide for some ease of use of the user aspirating the liquid from the absorptive ceramic reservoir 76024. The macroporous ceramic may have an air entry value within a range from approximately one fifth of a pound per square inch to approximately eight pounds per square inch. The macroporous ceramic may have a porosity within a range from approximately forty percent to approximately ninety percent. The macroporous ceramic may have an average pore size within a range from approximately twenty five microns to approximately one hundred and fifty microns.
In addition to providing some ease of aspiration, parameters such as porosity greater than approximately forty percent and/or average pore size greater than approximately twenty five microns may provide some wicking efficiency, in filling the absorptive ceramic reservoir 76024 with liquid. Parameters such as porosity less than approximately ninety percent and/or average pore size less than approximately one hundred and fifty microns may provide for some strength of the absorptive ceramic reservoir 76024. To provide some balance between ease of aspiration, wicking efficiency and strength, the macroporous ceramic may have an average pore size of approximately seventy microns.
Use of the previously described macroporous ceramic need not be strictly limited to the absorptive ceramic reservoir 76024. As will be discussed subsequently herein other vaporizer components may be comprised of the macroporous ceramic as just described.
The perspective exploded view of
Splatter shield 76052 may comprise an absorptive ceramic splatter shield.
Absorptive ceramic splatter shield 76052 may comprise the macroporous ceramic described and discussed previously herein. As already discussed, the macroporous ceramic may be substantially hydrophilic. Further, the macroporous ceramic may comprise a substantially open pore structured ceramic. Moreover, the macroporous ceramic may comprise a substantially interconnected macroporous ceramic.
As already discussed, the macroporous ceramic may comprise an oxide ceramic. More particularly, the macroporous ceramic may comprise Aluminum Oxide. Since the atomizer assembly 76050 may generate heat, to provide for some user safety the splatter shield 76052 may be substantially a non-flammable. To provide for some safety of the user inhaling vapors of the vaporizer, the splatter shield 76052 may be substantially chemically inert.
Parameters of the macroporous ceramic may be chosen so as to provide for some ease of use of air or vapor entry into the splatter shield 76052. The macroporous ceramic may have an air entry value within a range from approximately one fifth of a pound per square inch to approximately eight pounds per square inch. The macroporous ceramic may have a porosity within a range from approximately forty percent to approximately ninety percent. The macroporous ceramic may have an average pore size within a range from approximately twenty five microns to approximately one hundred and fifty microns.
In addition to providing some ease of air or vapor entry, parameters such as porosity greater than approximately forty percent and/or average pore size greater than approximately twenty five microns may provide some wicking efficiency, in filling as discussed in greater detail subsequently herein. Parameters such as porosity less than approximately ninety percent and/or average pore size less than approximately one hundred and fifty microns may provide for some strength of the splatter shield 76052. To provide some balance between ease of aspiration, wicking efficiency and strength, the macroporous ceramic may have an average pore size of approximately seventy microns.
Similarly, wick element 76057 of atomizer assembly 76050 shown in
As already discussed, the macroporous ceramic may comprise an oxide ceramic. More particularly, the macroporous ceramic may comprise Aluminum Oxide. Since the atomizer assembly 76050 may generate heat, to provide for some user safety the wick element 76057 may be substantially a non-flammable. To provide for some safety of the user inhaling vapors of the vaporizer, the wick element 76057 may be substantially chemically inert.
Parameters of the macroporous ceramic may be chosen so as to provide for some ease of use of the user aspirating the liquid from the wick element 76057. The macroporous ceramic may have an air entry value within a range from approximately one fifth of a pound per square inch to approximately eight pounds per square inch. The macroporous ceramic may have a porosity within a range from approximately forty percent to approximately ninety percent. The macroporous ceramic may have an average pore size within a range from approximately twenty five microns to approximately one hundred and fifty microns.
In addition to providing some ease of the user aspirating the liquid from the wick element 76057, parameters such as porosity greater than approximately forty percent and/or average pore size greater than approximately twenty five microns may provide some wicking efficiency, in filling as discussed in greater detail subsequently herein. Parameters such as porosity less than approximately ninety percent and/or average pore size less than approximately one hundred and fifty microns may provide for some strength of the wick element 76057. To provide some balance between ease of aspiration, wicking efficiency and strength, the macroporous ceramic may have an average pore size of approximately seventy microns.
As shown in shown in
More generally,
As shown in shown in
Substantially non-absorptive member 76058 may be thermally coupled with the heating element 76054 for changing liquid into vapor. Substantially non-absorptive member 76058 may have a surface area that is greater than a surface area of the heating element 76054 for changing the liquid into the vapor. Heating element 76054 may comprise wire coiled about the substantially non-absorptive member 76058. Substantially non-absorptive member 76058 may have a thermal conductivity that is substantially less than a thermal conductivity of the heating element 76054. Substantially non-absorptive member 76058 may be proximally arranged with the heating element 76054 for substantially reflecting heat from the heating element 76054. Substantially non-absorptive member 76058 may maintain a temperature less than approximately two hundred and eighty degrees Celsius during activation of the heating element 76054.
More generally,
Heating element support member 76058 may be substantially hydrophobic.
Heating element support member 76058 may comprise glass. Heating element support member 76058 may comprise a ceramic. Heating element support member 76058 may comprise stabilized zirconia.
More particularly, first pressure member 76055 may comprise a pressure cap which may sandwich the first extremity of the heating element 76054 over the inner contact member 76051 to effect first solderless pressure contacts. Inner contact member 76051 and first pressure member 76055 may comprise metal members. Inner contact member 76051 may comprise an inner contact post.
As shown in
Electrical insulation material 76056 may be interposed between the inner contact member 76051 and the outer contact member 76053. Substantially annular insulation 76056 may be interposed between the inner contact member 76051 and the outer contact member 76053. The electrical insulation material 76056 may be selected for substantially avoiding outgassing at approximately three hundred degrees Celsius. The electrical insulation material 76056 may be selected for substantially maintaining dimensional stability at approximately three hundred degrees Celsius. The electrical insulation material 76056 may comprise polytetrafluoroethylene.
As shown in
In other words,
The absorptive ceramic reservoir of the vaporizer may be arranged for filling, or refilling, by the user dripping liquid. For example,
The aspiration channel 76026A, 76026B may be coupled with the wick element 76057 for bubbling air into the wick element 76057 in response to aspiration by the user's mouth. The aspiration channel 76026A, 76026B may be coupled with the wick element 76057 for aspirating liquid into the wick element 76057 in response to aspiration by the user's mouth.
More generally, the aspiration channel 76026A, 76026B may be coupled with absorptive member 76057 for bubbling air into the absorptive member 76057 in response to aspiration by the user's mouth. The aspiration channel 76026A, 76026B may be coupled with absorptive member 76057 for aspirating liquid into the absorptive member 76057 in response to aspiration by the user's mouth.
As depicted in
Operation of vaporizer 76000 is depicted in various sequential views in
The battery carrier sleeve 76008 may be disposed within the housing 76002.
The housing 76002 may have aperture 76010 extending into the housing 76002 and arranged adjacent to the surface of the battery carrier sleeve 76008. The surface of the battery carrier sleeve 76008 may be arranged so as to be manually accessible through the aperture 76010 by the user for controlling the movement of battery carrier sleeve 76008 between the retracted position and the extended position. In
In subsequent sequential side view in
In subsequent sequential side view in
As particularly shown in
As particularly shown in
In other words,
The electrical switch may be a momentary on-off switch. Momentary on-off switch may be “on”, as shown in
Without absorptive ceramic reservoir, vaporizer 79000 shown in
The battery carrier sleeve 79008 may be disposed within the housing 79002.
The housing 79002 may have an aperture 79010 extending into the housing 79002 and arranged adjacent to a surface of the battery carrier sleeve 79008. The surface of the battery carrier sleeve 79008 may be arranged so as to be manually accessible through the aperture 79010 by a user for controlling the movement of battery carrier sleeve 79008 between the retracted position and the extended position.
The advantages of the invention are numerous. Different aspects, embodiments or implementations may yield one or more of the following advantages. One advantage may be that soldering of the heating element may be substantially avoided. Another advantage may be that toxic lead and/or toxic lead vapors of lead based solder may be substantially avoided. Another advantage is that upon heating of the atomizer assembly, user inhalation of toxins from lead based solders may be substantially avoided. Another advantage is that solderless pressure contacts may provide ease or efficiency in assembly.
Cartridge liquid reservoir main body 8312 is configured to be disposed within cartridge chamber main body 8311. Likewise, atomizer housing 8340 is configured to be disposed within cartridge chamber main body 8311. Atomizer housing 8340, its contents, and cartridge liquid reservoir main body 8312 may comprise an integrated unit (a.k.a. cartomizer).
In
The Use of Digital Application(s) for Device Monitoring, Device Control, Data Storage, Data Analysis, Data Transmission, User Support, Social Networking, Usage Information, and Purchasing Data/Metrics
The digital applications of a vaporizer device can be used for multiple functions. Exemplary functions are described below. For example, the use of the onboard CPU/PCB and data gathering, data analysis, and data transmission methods are used to interface with digital consumer technology products such as smart phones, tablet computers, lap top/netbook/desktop computers, wearable wireless technologies such as “smart watches,” and other wearable technology such as Google “Glass” or similar through the use of programming, software and GUI, general and commonly referred to as application(s) or “apps” and referred to in this section as application(s).
Wired means may be used for a connection to interface the device and device active case to digital consumer technology products for the purpose of the transmission and exchange of data from the device and device active case to the digital consumer technology products and vice-versa. Likewise, wireless means may be used for the connection to interface the device and device active case to digital consumer technology products for the purpose of the transmission and exchange of data from the device and device active case to the digital consumer technology products and vice-versa. Wireless means for connection may include Wi-Fi, Bluetooth, infrared or similar to interface the device and device active case to digital consumer technology products for the purpose of the transmission and exchange of data from the digital consumer technology products to device and device active case.
Wired or wireless means of connection may be used from the digital consumer technology products to device and device active case as a means of relaying information and data to add additional functionality to the vaporizer. Examples of the functionality are described below. Those examples may include various means for user control of the functionality, features, configurations and similar of the device and associated application through the use of various features of the application referred to as application configurations or “settings” and referred to subsequently as setting. The examples include:
The application may provide an authentication process to activate the device. The application may provide an authentication process to activate the device that verifies the users age at or prior to establishing a unique identification profile for the end user to prevent unintended use or abuse of the device by minors. User demographic, socioeconomic, and device usage data may establish a user profile. Pooled user profiles can establish a starting configuration of device settings for a new user based on pooled data on usage and settings of similar users based wholly or partially on demographic, socioeconomic, and device usage data. The application can provide information to the user on the operation of the device. The application can provide the user with information on how to configure, adjust, modulate, modify, or similar the device settings. The application can provide information on trouble shooting the device in the event of a performance issue or malfunction. The application can provide safety information relating to the device to the user. The application can provide safety information relating to the maintenance, cleaning, or similar activities for the device. The application can provide storage information for the device. The application can provide information relating to the disposal or recycling of the device. The application can provide information on the proper disassembly and assembly of the device. The application can provide information such as the manufacturers, distributors, retailers, or similar website and or contact information. The application can provide information such as a website URL or link for internet forums that may relate to the use, troubleshooting, user experience, user reviews or similar. The application can provide safety information relating to the device to the user. The application can provide information on available products, accessories, or similar that may be related to the device. The application can provide a space for advertising consumer products or services that may be related to the device. The application can provide functions relating to personal user goals for device usage and to track usage as it relates to the users defined goals and to prevent the data in the forms of charts, graphs, or similar.
According to an embodiment,
A personal digital device 10810 is capable of sharing data with PVU 100 and/or case 500 through both wired methods such as data cables, and through wireless methods such as WiFi, Bluetooth, cellular networks, IR or similar technologies. Personal digital devices 10810 may use software (collectively or commonly referred to as applications or “apps”) that provide a graphical user interface (GUI)—e.g., application 10820. A GUI may provide a convenient way for the user to interact with application 10820. Application 10820 may facilitate the transferring of data from PVU 100 and/or case 500 to the personal digital device 10810. Application 10820 may facilitate the transferring of data to PVU 100 and/or case 500 from the personal digital device 10810.
According to an embodiment,
In an embodiment, PVU 100 and/or case 500 may interact in a network directly by using onboard wired and wireless data transmitting methods. PVU 100 and/or case 500 may interact in a network indirectly through the use of wired and wireless connection methods that interfacing via an application 10820 running on a personal digital device 10810. Some data (e.g., anonymous user and device performance data 10960) may be shared directly to network 10940 without the use of personal digital device 10810. Some data may be shared with network 10940 through application 10820 running on a personal digital device 10810. The types of data shared directly both in relation to data transmitted and data received depends on the configuration of PVU 100, case 500, and/or application 10820. Personal digital device 10810 may not be required for the transmission of data to network 10940 or receipt of data from network 10940 (e.g., software and system updates, user selected settings 10980). Personal digital device 10810 can provide a desirable and common platform (e.g., GUI) for interfacing with the end user.
According to an embodiment,
In an embodiment, some PVU 100 and/or case 500 data can be sent and received directly to and from network 10940. Some PVU 100 and/or case 500 data can be sent and received directly to and from network 10940 for further communication with social network 11041, health care network 11042, social/support group 11043, retailer 11044, and/or manufacturer 11045. Some data can be shared with the end user's personal digital device 10810 through the use of an application (e.g., application 10820) and then subsequently shared with via network 10940. The end users personal digital device 10810 can also be used to receive data from social network 11041, health care network 11042, social/support group 11043, retailer 11044, and/or manufacturer 11045. This data may be further shared with PVU 100 and/or case 500. Different entities may contribute to network 10940 data flow including end user 11051, PVU 100 and/or case 500, personal digital device 10810, social network 11041, health care network 11042, social/support group 11043, retailer 11044, and/or manufacturer 11045, and others, may each contribute to data that is shared in system 11000.
According to an embodiment,
In an embodiment, an application (e.g., application 10820) running on personal digital device 10810 provides an interface for the end user to engage and interact with functions related to communication of data to and from PVU 100 and/or case 500. In an embodiment, a user can control some aspects of the data transmission and data receiving to and from PVU 100 and/or case 500. Some data can be communicated as a background operation such that the end user does not have to initiate or authorize the data communication process.
Background processes of data communication can occur whenever a respective PVU 100 and/or case 500 is operatively coupled to the end users personal digital device 10810 (either through wireless or wired methods.) Various icons and text elements may inform the user of various ways that PVU 100 and/or case 500 settings can be adjusted or configured by the user. Various icons and text elements can provide a means for the user to see information about PVU 100 and/or case 500—such as battery information and similar device status. Various icons and text elements can provide a means for the user to update PVU 100 and/or case 500 internal software (a.k.a., firmware). Various icons and text elements can provide a means for the user to set security and/or authorization features of PVU 100 and/or case 500—such as setting a PIN code to activate the device or the use of personal biometric information as a means of authentication. Various icons and text elements can provide a means to configure foreground data sharing and related settings.
According to an embodiment,
The authentication process can be embodied as a feature of an application (e.g., application 10820) that is installed and running on personal digital device 10810. In
In an embodiment, PVU 100 and/or case 500 may be rendered inactive after a period of inactivity. This is similar to a computer going into “sleep mode” when there is no usage detected for a predetermined and preset period of time. In order for PVU 100 and/or case 500 to be activated, and thereby be capable of being used by the user for the purpose of generating vapor, the user must be authenticated to insure that the device is being utilized by the intended end user, and to prevent unauthorized use, or accidental, or unintended activation of the device, or use of the device by an individual not of legal age to ingest the active component—such as nicotine. PIN based authentication 11201 process uses a user selected PIN code to authenticate the end user. Fingerprint based authentication 11202 process uses the user fingerprint to authenticate the end user. Iris scan based authentication 11203 process uses an eye or iris scan, or the like, to authenticate the end user. Facial recognition based authentication 11204 uses a face scan or image processing algorithm to authenticate the end user. Iris scan based authentication 11203 and facial recognition based authentication 11204 are easier to use if the user's personal digital device has a forward facing (on the same surface as the primary touch screen interface or similar) camera.
In an embodiment, personal vaporizer unit 100 (and circuitry on PC-board 123, in particular) may perform onboard data gathering, data analysis, and/or the data transmission methods described herein. PVU 100 may interface with digital consumer technology products such as smart phones, tablet computers, lap top/netbook/desktop computers, wearable wireless technologies such as “smart watches,” and other wearable technology such as Google “Glass,” or similar through the use of programming, software, firmware, GUI, wireless communication, wired communication, and/or software commonly referred to as application(s) or “apps.” Likewise, in an embodiment, case 500 may perform data gathering, data analysis, and/or the data transmission methods described herein. Case 500 may interface with digital consumer technology products such as smart phones, tablet computers, lap top/netbook/desktop computers, wearable wireless technologies such as “smart watches,” and other wearable technology such as Google “Glass,” or similar through the use of programming, software, firmware, GUI, wireless communication, wired communication, and/or software running on these devices (commonly referred to as application(s) or “apps.”)
Wired means can be used to interface PVU 100 and/or case 500 to digital consumer technology products for the purpose of the transmission and exchange of data to/from PVU 100 or case 500 from/to the digital consumer technology products (and thereby also interfacing with apps running on the digital consumer technology products.) Wireless means can be used to interface PVU 100 and/or case 500 to digital consumer technology products for the purpose of the transmission and exchange of data to/from PVU 100 or case 500 from/to the digital wireless interface. PVU 100 and/or case 500 may use a wireless means/interface that includes one or more of an infrared (IR) transmitter, a Bluetooth interface, an 802.11 specified interface, and/or communications with a cellular telephone network in order to communicate with consumer technology products (and thereby also interfacing with apps running on the digital consumer technology products).
In an embodiment, PVU 100 and/or case 500 can interface (i.e., communicate) with digital consumer technology products and with apps as a way of relaying information and data to add additional functionality to PVU 100. This additional functionality may include (but is not limited to): (a) setting and/or specifying a desired number of activation cycles over a period of time; (b) setting and/or specifying reminders, alarms, or similar to notify the user; (c) setting and/or specifying a desired dose(s) for delivery of active substance(s) per inhalation; (d) setting and/or specifying a desired total delivered dose of active substance(s) over a period of time—such as a total daily dose; (e) setting and/or specifying power settings of PVU 100 to modulate the vapor and/or aerosol strength, vapor and/or aerosol density, vapor and/or aerosol volume, vapor and/or aerosol flavor, vapor and/or aerosol temperature, and/or similar vapor and aerosol characteristics of the vapor or aerosol generated by the PVU 100; (f) setting and/or specifying power settings of PVU 100 to modulate, adjust, configure or similar the settings of the device as they relate to battery life and/or performance; (g) setting and/or specifying configurations of PVU 100 related to the liquid components and formulation; (h) setting and/or specifying ambient temperature based environmental configurations; (i) setting and/or specifying humidity based environmental configurations; (j) setting and/or specifying altitude based environmental configurations; (k) setting and/or specifying temporal (i.e., time) based configurations; (l) setting and/or specifying parameters to minimize, maximize, and or modulate the functional effects of the taste and/or flavor component of the vapor product; (m) setting and/or specifying functional effect parameters to minimize or maximize the functional effects related to pharmacodynamics and pharmacokinetics of an active ingredient or drug component of the vapor or aerosol product; (n) receiving and/or providing to a user, PVU 100 and/or case 500 alerts and notifications; (o) receiving and/or providing to a user, PVU 100 alerts and notifications related to recharging (e.g., whether a battery 104 needs to be recharged); (p) receiving and/or providing to a user, case 500 alerts and notifications related to recharging; (q) receiving and/or providing to a user, PVU 100 alerts and notifications related to charge status (e.g., whether a battery 104 is fully or partially charged); (r) receiving and/or providing to a user, case 500 alerts and notifications related to charge status; (s) receiving and/or providing to a user, PVU 100 alerts and notifications related to liquid cartridge usage status—such as a number of usages or inhalations taken from a cartridge; (t) receiving and/or providing to a user, PVU 100 alerts and notifications related to liquid cartridge remaining status—such as a number of usages or inhalations remaining in a cartridge; (u) receiving and/or providing to a user, PVU 100 alerts and notifications related to time-based liquid cartridge usage status—such as number of usages or inhalations taken over a preset or predetermined period of time, for example number of usages or inhalations taken per day; (v) receiving and/or providing to a user, PVU 100 alerts and notifications related to liquid cartridge contents—such as active component(s), strength, dosage (or similar), flavor profile (or similar), and general formulation (or similar); (w) receiving and/or providing to a user, PVU 100 alerts and notifications related to liquid cartridge, liquid cartridge assembly, or similar, requiring replacement; (x) receiving and/or providing to a user, PVU 100 alerts and notifications related to preset times for usage of PVU 100; and, (y) receiving and/or providing to a user, PVU 100 heating element alerts and notifications status or “health”—such as number of cycles performed, and/or number of cycles remaining before suggested and/or required replacement of a heating element or heating element assembly.
In an embodiment, the power settings of PVU 100 may be set and/or specified to modulate or configure the activation energy delivered to the heating element(s) as well as modulating or configuring the parameters of the heating element(s) being energized in relation to the time to peak activation or “warm up” or “ramp” and or the time of maximum or peak activation, and or the time of the heating element being deactivated or the “cool down” to effect and modulate vapor and/or aerosol strength, vapor and/or aerosol density, vapor and/or aerosol volume, vapor and/or aerosol flavor, vapor and/or aerosol temperature, and/or similar vapor and aerosol characteristics of the vapor or aerosol generated by the PVU 100. In an embodiment, the power settings of PVU 100 may be set and/or specified such that the user can make setting adjustments to PVU 100 to maximize battery life. In this case, PVU 100 will resultantly operate at lower energy output to preserve the maximum number of cycles that be sustained per battery 104 charge cycle. Conversely the power settings of PVU 100 may be set and/or specified such that the user can maximize performance in relation to the energy output of the device per cycle.
In an embodiment, the liquid related settings of PVU 100 can be based on information about the liquid components and/or formulation, or similar such that the information relating to the liquid to be vaporized or aerosolized. The liquid related settings of PVU 100 can have predetermined as well as user configurable settings to modulate, configure, adjust or otherwise configure the device activation parameters. In an embodiment, settings related to user specific environmental configurations can be made such that PVU 100 optimizes heating element activation and activation parameters to optimize performance based on ambient temperature, humidity, and/or altitude. For example, PVU 100 may have configurations such as cold weather or warm weather settings, humidity settings, and/or altitude settings.
In an embodiment, PVU 100 can be configured (programmed) with time based settings. For example, user specific temporal configurations such as the user preferring higher active component delivery per inhalation at specific times of the day. PVU 100 can be configured such that PVU 100 delivers dosages of an active component based on the time of day. For example, PVU 100 can be configured such that such that the dosage delivered to the user is highest, or at maximum value (or similar) in the morning and tapers down to a lower delivered dose per inhalation, or minimum value (or similar) at the end of the evening. The user can program these settings (and others described herein) based on personal preference.
In an embodiment, taste and/or flavor related settings of PVU 100 can minimize, maximize, and or modulate the functional effects of the taste and/or flavor component of the vapor product. For example, PVU 100 can be configured to activate in such a way that the flavor delivered from the vapor or aerosol is minimized, maximized, or modulated over the period of an inhalation. Some components of the liquid being vaporized that may contribute to the flavor characteristics of the vapor or aerosol may be more profound, more prevalent, or more substantial when PVU 100 is activated with higher temperature ranges being generated by the heating element than when lower temperature ranges are being generated by the heating element (within the range of temperatures that the heating element may operate in order to generate a vapor or aerosol for inhalation by the user.) For example the user may set PVU 100 to perform for maximal, minimal, moderate, or another interim value of flavor for the vapor or aerosol product. PVU 100 can modulate the heating element activation cycle accordingly.
In an embodiment, functional effect related setting of PVU 100 can minimize, maximize, or modulate the functional effects related to pharmacodynamics and pharmacokinetics of an active ingredient or drug component of the vapor or aerosol product. For example, PVU 100 can be configured to activate in such a way that the active component or drug delivered from the vapor or aerosol is minimized or maximized in terms of target tissue or organ delivery. Active components or drug(s) in a liquid formulation being vaporized can be absorbed into the blood stream at different rates depending on the target tissue or organ.
Active component(s) or drug(s) in a vapor having a small particle size of less than 10 microns may be readily absorbed into systemic circulation through the pulmonary vasculature. However active component(s) or drug(s) in a vapor having a small particle size of greater than 10 microns may be absorbed more preferentially through the mucosal surface of the oral and pharyngeal cavities. Mucosal absorption is slower to reach the systemic circulation than delivery of a drug (or similar) to the systemic circulation through the pulmonary vasculature.
A user may be using PVU 100 for the delivery of nicotine as the active or drug component in the vapor or aerosol. It may be desirable for (or by) the user to have an option for more rapid delivery of the nicotine to the bloodstream—such as after a period of time of not having nicotine (when that the user's urge or craving is likely to be elevated.) Alternatively, at times it may be desirable for (or by) the user to have a slower absorption of nicotine into the blood stream such as at times when: (i) the users craving or urge is low, (ii) when the user wants to have a more prolonged period of time before they have the urge or craving for nicotine—such as prior to going to sleep, or an event where they will be unable to use the device for dosing or administration of the nicotine. PVU settings relating to the activation of the device and the temperature of the heating element and heating element activation characteristics may be modulated such that, for example, at lower temperature activation the particle size of the drug component is larger than at times of a higher temperature activation of the heating element. Thus, by modulating the input of thermal or heat energy inputted into the vaporization chamber by the heating element to volatize or vaporize the liquid containing the active component(s) or drug(s) the characteristics of the vapor or aerosol in relation to the particle size of the active component(s) or drug(s) can be wholly or partially modulated by the user. These settings can also be used by the end user or healthcare provider (or similar) to reduce dependence on the active component(s) or drug(s)—such as nicotine. These settings can also be used, for example, by initially using the device configured to maximize pulmonary deliver of the nicotine and then transition to device settings that maximize mucosal delivery of the nicotine as a means to facilitate a reduction in nicotine dependence. This transition can also be used in conjunction with nicotine dosage reduction as a means of reducing or mitigating the users nicotine dependence or addiction.
In an embodiment, an app may receive alerts and notifications associated with PVU 100 and/or case 500. These alerts and notifications can include, for example: battery life status, battery condition data (such as number of battery cycles), battery “health” (such that the user can be notified, as desired, to the current and “real time” overall condition of the PVU 100 and/or case 500's internal battery(s).
In an embodiment, PVU 100, case 500, and/or an associated application (app) running on a digital consumer technology product may share data with a manufacturer, manufacturer affiliate, or other entity (retailer, healthcare provider, supplier, marketing entity, etc.) Case 500 may share data via an associated application. PVU 100 may share data via case 500 and/or directly to an associated application (for further sharing with another entity).
PVU 100, case 500, and/or an associated application can gather, receive, logging, store, transmit, extrapolate, and/or the like, anonymous or user specific usage data—such as frequency of use. PVU 100, case 500, and/or an associated application can gather, receive, logging, store, transmit, extrapolate, and/or the like, user specific usage data such as activation cycle characteristics such as duration of activations and user specified activation settings (if applicable.) PVU 100, case 500, and/or an associated application can gather, receive, logging, store, transmit, extrapolate, and/or the like, user specific demographic information. PVU 100, case 500, and/or an associated application can gather, receive, logging, store, transmit, extrapolate, and/or the like, user specific socioeconomic information. PVU 100, case 500, and/or an associated application can gather, receive, logging, store, transmit, extrapolate, and/or the like, user specific f information. PVU 100, case 500, and/or an associated application can gather, receive, logging, store, transmit, extrapolate, and/or the like, user specific feedback information. PVU 100, case 500, and/or an associated application can gather, receive, logging, store, transmit, extrapolate, and/or the like, user specific demographic information. PVU 100, case 500, and/or an associated application can gather, receive, logging, store, transmit, extrapolate, and/or the like, user specific feedback information through the use of surveys, polls, and the like, and/or data analytics.
PVU 100, case 500, and/or an associated application can gather, receive, logging, store, transmit, extrapolate, and/or the like, anonymous and/or user specific usage and/or reliability data such as device errors or malfunctions. PVU 100, case 500, and/or an associated application can gather, receive, logging, store, transmit, extrapolate, and/or the like, user specific usage and/or reliability data such as requests for warranty services, repairs, and or replacements, etc. PVU 100, case 500, and/or an associated application can gather, receive, logging, store, transmit, extrapolate, and/or the like, user specific customer satisfaction data such as requests for technical support. PVU 100, case 500, and/or an associated application can gather, receive, logging, store, transmit, extrapolate, and/or the like, user specific sales lead data such as requests for product information. PVU 100, case 500, and/or an associated application can gather, receive, logging, store, transmit, extrapolate, and/or the like, user specific usability data such as requests for usage instructions. PVU 100, case 500, and/or an associated application can gather, receive, logging, store, transmit, extrapolate, and/or the like, user specific information such as requests for information on product features or functions. PVU 100, case 500, and/or an associated application can gather, receive, logging, store, transmit, extrapolate, and/or the like, user specific marketing data such as requests for information on purchasing PVU 100 or case 500 and/or acquiring PVU 100 or case 500 by way of a prescription from a physician or healthcare provider.
PVU 100, case 500, and/or an associated application can gather, receive, logging, store, transmit, extrapolate, and/or the like, PVU 100 data indicating misuse or abuse of PVU 100. PVU 100, case 500, and/or an associated application can gather, receive, logging, store, transmit, extrapolate, and/or the like, PVU 100 and case 500 data and/or data transmission features that can be used to locate PVU 100 and/or case 500. PVU 100, case 500, and/or an associated application can gather, receive, logging, store, transmit, extrapolate, and/or the like, PVU 100 and case 500 data and/or data transmission features that can be used to locate PVU 100 and/or case 500 if PVU 100 or case 500 is lost or stolen. PVU 100, case 500, via an associated application, can gather, receive, logging, store, transmit, extrapolate, and/or the like, notifications regarding product recalls or similar issues and/or inform the user of such recalls or issues. PVU 100, case 500, via an associated application, can gather, receive, logging, store, transmit, extrapolate, data sharing, and/or the like, notifications manufacturer terms and conditions (e.g., cartridge manufacturer) and/or inform the user of such terms and conditions, and/or receive approval of such terms and conditions from the user.
PVU 100, case 500, via an associated application, can gather, receive, logging, store, transmit, extrapolate, data share, and/or the like, data from a network that may be used to identify, contact, or connect with other users of PVU 100. PVU 100, case 500, via an associated application, can gather, receive, logging, store, transmit, extrapolate, data share, and/or the like, data from a network that may be used to identify, contact, or connect with other users of PVU 100 wherein the network comprises a wireless communication link. PVU 100 and/or case 500 may select and/or authorize the sharing of all or some of the data gathered, received, logged, stored, transmitted, extrapolated, shared, or the like by the PVU 100 and/or case 500, or gathered directly from the user through the use of applications associated with PVU 100 and/or case 500. PVU 100 and/or case 500 may select and/or authorize the sharing, via a network, of all or some of the data gathered, received, logged, stored, transmitted, extrapolated, shared, or the like by the PVU 100 and/or case 500, or gathered directly from the user through the use of applications associated with PVU 100 and/or case 500. The network may comprise social media. The social media membership may comprise a user's family. The social media membership may comprise a user's friends. The social media membership may comprise a support group or similar (e.g., quit smoking group). The social media membership may comprise a third party service, company, organization (e.g., church), other users of PVU 100, or the like.
PVU 100, case 500, and/or an associated application can gather, receive, logging, store, transmit, extrapolate, and/or the like, data useful to perform software configuration of the device and or the device application(s). PVU 100, case 500, and/or an associated application can gather, receive, logging, store, transmit, extrapolate, and/or the like, data useful or required to perform software configuration of the PVU 100, case 500, and/or the associated application(s). PVU 100, case 500, and/or an associated application can gather, receive, logging, store, transmit, extrapolate, and/or the like, data useful or required to perform software configuration of the PVU 100, case 500, and/or the associated application(s) where the software is configured by the manufacturer or manufacturers subsidiary or representatives or third party or similar. PVU 100, case 500, and/or an associated application can gather, receive, logging, store, transmit, extrapolate, and/or the like, data useful or required to perform third party software configuration of PVU 100, case 500, and/or the associated application(s). PVU 100, case 500, and/or an associated application can gather, receive, logging, store, transmit, extrapolate, and/or the like, data useful or required to perform firmware updates of PVU 100, case 500, and/or the associated application(s). PVU 100, case 500, and/or an associated application can provide for the notification of the user via PVU 100, case 500, and/or an associated application that a firmware or similar updates to PVU 100, case 500, and/or an associated application is available and or required as a means of trouble shooting the device or remediating a problem or issue with PVU 100, case 500, and/or an associated application which is preventing some aspect of intended or proper function(s) of PVU 100, case 500, and/or an associated application. PVU 100, case 500, and/or an associated application can provide for the notification of the user via PVU 100, case 500, and/or an associated application that a firmware or similar updates to PVU 100, case 500, and/or an associated application is available and or required as a means of means of providing additional functions relating to or intended to improved PVU 100 or case 500 performance, enhance user experience, or similarly improve some aspect of intended or proper function(s) of PVU 100, case 500, and/or an associated application.
PVU 100, case 500, and/or an associated application can share data gathered by PVU 100, case 500, or gathered directly from the user through the use of the application with the user's healthcare provider. PVU 100, case 500, and/or an associated application can share data gathered by PVU 100, case 500, or gathered directly from the user through the use of the application with the user's healthcare network. PVU 100, case 500, and/or an associated application can share data gathered by PVU 100, case 500, or gathered directly from the user through the use of the application with the user's insurance provider. PVU 100, case 500, and/or an associated application can share data gathered by PVU 100, case 500, or gathered directly from the user through the use of the application with the user's pharmacy and/or prescription drug provider, or the like. PVU 100, case 500, and/or an associated application can depersonalized or otherwise made anonymous data gathered by PVU 100, case 500, or gathered directly from the user so that the depersonalized data can be shared used for purposes such as research, analysis, publication, or similar purposes.
PVU 100, case 500, and/or an associated application can provide for the notification of the user via PVU 100, case 500, and/or the associated application of the availability of a prescription issued or written for the end user being ready for pick-up, delivery, shipment to the user or similar of a prescription component intended for delivery to the patient by PVU 100. For example, a pharmacy could send a notification to the user, via PVU 100, case 500, and/or an associated application, such as to notify the user that their prescription for PVU 100 or device components (e.g., cartridges or liquids) is available for the user to pick up from the pharmacy. PVU 100, case 500, and/or an associated application can allow for healthcare providers, networks, agents, authorized third parties or similar to send alerts, messages, surveys, or similar to the user via PVU 100, case 500, and/or the associated application. PVU 100, case 500, and/or an associated application can allow for healthcare providers, networks, agents, authorized third parties or similar to access data that is generated as a result of surveys, or similar through PVU 100, case 500, and/or the associated application.
PVU 100, case 500, and/or an associated application can authorize (i.e., allow) a healthcare provider to configure, adjust, modulate, and/or manipulate PVU 100 settings. PVU 100, case 500, and/or an associated application can authorize a healthcare provider to configure, adjust, modulate, and/or manipulate PVU 100 settings which the user is not authorized to change, alter, reconfigure or change the settings, configurations, etc. made by the healthcare provider. PVU 100, case 500, and/or an associated application can authorize a representative or agent of the healthcare provider to configure, adjust, modulate, and/or manipulate PVU 100 settings which the user is not authorized to change, alter, reconfigure or change the settings, configurations, etc. made by the representative or agent of the healthcare provider. PVU 100, case 500, and/or an associated application can share user specific information, such as end user ownership of products relating to the device, device components, device accessories or similar data, gathered by PVU 100, case 500, or gathered directly from the user through the use of the application. PVU 100, case 500, and/or an associated application can share user specific information, user specific information such as end user purchasing of products relating to the device, device components, device accessories or similar data, gathered by PVU 100, case 500, or gathered directly from the user through the use of the application. PVU 100, case 500, and/or an associated application can provide for the notification of the user via PVU 100, case 500, and/or the associated application of notifications from retailer(s) or similar regarding product promotions. PVU 100, case 500, and/or an associated application can provide for the notification of the user via PVU 100, case 500, and/or the associated application similar of notifications from retailer(s) or similar regarding product availability. PVU 100, case 500, and/or an associated application can provide for the notification of the user via PVU 100, case 500, and/or the associated application similar of notifications from retailer(s) or similar regarding release of new product or accessories.
PVU 100, case 500, and/or an associated application can use demographic or similar location services to find retail locations in geographic proximity of the user. PVU 100, case 500, and/or an associated application can gather, receive, logging, store, transmit, extrapolate, and/or the like, data relating to device purchasing, device accessories purchasing, vaporizer liquid and associated packaging or assembly purchasing, frequency of purchasing, point of sale, discounts applied by user when purchasing, and related or similar information. PVU 100, case 500, and/or an associated application can gather, receive, logging, store, transmit, extrapolate, and/or the like, data relating to device purchasing, device accessories purchasing, vaporizer liquid and associated packaging or assembly purchasing, frequency of purchasing, point of sale, discounts applied, and related or similar information.
PVU 100, case 500, and/or an associated application can provide incentives to the user to share information relating to device purchasing, device accessories purchasing, vaporizer liquid and associated packaging or assembly purchasing, frequency of purchasing, point of sale, discounts applied and related information such as discounts, coupons, promotional codes, free items, or similar. PVU 100, case 500, and/or an associated application can provide for the use of the user profile to provide targeted incentives to the user to share information relating to device purchasing, device accessories purchasing, vaporizer liquid and associated packaging or assembly purchasing, frequency of purchasing, point of sale, discounts applied, promotional codes used, and related information such as discounts, coupons, free items, or similar.
PVU 100, case 500, and/or an associated application can render PVU 100 inactive and unable to be used. PVU 100, case 500, and/or an associated application can render PVU 100 inactive and unable to be used if a malfunction or similar has occurred. PVU 100, case 500, and/or an associated application can render PVU 100 inactive and unable to be used until the authorized user enters a Personal Identification Number (PIN) using the application which then activates PVU 100. PVU 100, case 500, and/or an associated application can render PVU 100 inactive and unable to be used until the authorized user has a biometric identifier that when recognized or confirmed or verified or similar, using the application or case 500, activates PVU 100. PVU 100, case 500, and/or an associated application can render PVU 100 inactive and unable to be used until the authorized user uses a fingerprint as a biometric identifier that when recognized or confirmed or verified or similar, using the application or case 500, activates PVU 100. PVU 100, case 500, and/or an associated application can render PVU 100 inactive and unable to be used until the authorized user uses an eye, or iris, or similar scan, as a biometric identifier that when recognized or confirmed or verified or similar, using the application or case 500, activates PVU 100. PVU 100, case 500, and/or an associated application can render PVU 100 inactive and unable to be used until the authorized user is recognized or confirmed or verified or similar, using facial recognition, the application or case 500, activates PVU 100.
Unauthorized use of PVU 100, case 500, and/or an associated application can be prevented by using PIN or unique biometric identifier to enable PVU 100, case 500, and/or an associated application. PVU 100, case 500, and/or an associated application can share data relating to the attempted unauthorized use of PVU 100. PVU 100, case 500, and/or an associated application can share data over a network to authorize the user and activate PVU 100. PVU 100, case 500, and/or an associated application can share data such that biometric authentication can be performed through the use of a network. PVU 100, case 500, and/or an associated application can use time or duration of time that passes after use before PVU 100 is rendered inactive and authentication is required to authorize PVU 100.
PVU 100, case 500, and/or an associated application can save device data and personal settings for individual users so that more than one user may use PVU 100 and/or case 500. PVU 100, case 500, and/or an associated application can save device data and personal settings to be saved for individual users where the settings for device data and personal settings for different users can be applied to PVU 100 and/or case 500 and the intended user through the application and the user may select their saved configurations for PVU 100 and/or case 500 and the respective device will operate under that user selected configuration. PVU 100, case 500, and/or an associated application can have the ability for the user or users to have one or more of user settings and/or configurations that are saved and can be selected by users. PVU 100, case 500, and/or an associated application can have the ability to allow saved user settings and personal settings or configurations to be shared by the user through the application and/or an associated network. PVU 100, case 500, and/or an associated application can allow other user settings and/or configurations to be shared with the user through the application or an associated network.
PVU 100, case 500, and/or an associated application can have the ability to facilitate, prompt, or the like, a user to rate (such as through common methods such a 1-10 where “10” is the best, or 1-5 “stars” where “5” stars is the best) their user configurations. PVU 100, case 500, and/or an associated application can have the ability to facilitate, prompt, or the like, the user to rate other user configurations. PVU 100, case 500, and/or an associated application can have the ability to share and access a data base of user configurations that may or may not have ratings and be able to access the user configurations through the application and download user configurations for use in the users own device. PVU 100, case 500, and/or an associated application can have the ability to share and access a data base of user configurations that may or may not have ratings and a be able to access the user configurations through the application and upload their user configurations for use in other users devices.
PVU 100, case 500, and/or an associated application can share user data with the manufacturer, manufacturers subsidiaries, manufactures agents, or a third party for the purpose of generating user profiles based on user specific usage data, demographic data, socioeconomic data or similar. PVU 100, case 500, and/or an associated application can have the ability to utilize user data shared with the manufacturer, manufacturers subsidiaries, manufactures agents, or a third party to determine specific user profiles.
PVU 100, case 500, and/or an associated application can allow, facilitate, authorize, confirm or similar the sharing of data between the associated application and other application(s) that may be installed or a component of the user's personal digital device. PVU 100, case 500, and/or an associated application can share information and/or data with a social media application. PVU 100, case 500, and/or an associated application can share information and/or data with email service, email provider, email hosting, or similar application. PVU 100, case 500, and/or an associated application can share information and/or data with text message, SMS, or similar application. PVU 100, case 500, and/or an associated application can share information and/or data with a location based services application. PVU 100, case 500, and/or an associated application can share information and/or data with a map or mapping, navigation, location or similar application. PVU 100, case 500, and/or an associated application can share information and/or data with healthcare, healthcare provider, healthcare services, healthcare network or similar application. PVU 100, case 500, and/or an associated application can share information and/or data with pharmacy, or pharmacy type service provider or similar application. PVU 100, case 500, and/or an associated application can share information and/or data with a weather, or weather forecasting, or weather reporting, or similar application. PVU 100, case 500, and/or an associated application can share information and/or data with the device manufacturers application. PVU 100, case 500, and/or an associated application can share information and/or data with a research or research orientated application. PVU 100, case 500, and/or an associated application can share information and/or data with a PVU 100 and/or case 500 retailer or similar consumer device application.
PVU 100, case 500, and/or an associated application can have the ability to authorize or allow data gathering, receiving, logging, storing, transmission, extrapolation or similar for the purpose of the device or associated application sending error codes or error reports to the manufacturer, manufacturers subsidiaries, manufactures agents, or a third party for the purpose of addressing problems with device performance or function. PVU 100, case 500, and/or an associated application can have the ability to authorize or allow data gathering, receiving, logging, storing, transmission, extrapolation or similar for the purpose of the device or associated application sending error codes or error reports to the manufacturer, manufacturers subsidiaries, manufactures agents, or a third party for the purpose of addressing problems with device application(s). PVU 100, case 500, and/or an associated application can have the ability to authorize or allow data gathering, receiving, logging, storing, transmission, extrapolation or similar for the purpose of the device or device application sending error codes or error reports to the manufacturer, manufacturers subsidiaries, manufactures agents, or a third party for the purpose of extrapolating data metrics that relate to device malfunctioning. PVU 100, case 500, and/or an associated application can have the ability to authorize or allow data gathering, receiving, logging, storing, transmission, extrapolation or similar for the purpose of the device or associated application sending error codes or error reports to the manufacturer, manufacturers subsidiaries, manufactures agents, or a third party for the purpose of gathering, receiving, logging, storing, transmission, extrapolation or similar data that may relate to manufacturing, or quality control or similar issues or potential problems related to the device, device components, or liquid being used in the device. PVU 100, case 500, and/or an associated application can have the ability to gather, receive, log, store, transmit, extrapolate, or similar, data for the purpose of troubleshooting device issues or problems. PVU 100, case 500, and/or an associated application can have the ability to gather, receive, log, store, transmit, extrapolate, or similar, data for the purpose of troubleshooting device issues or problems that may relate to user error.
PVU 100, case 500, and/or an associated application can have the ability to use methods of data transmission such as wireless and wired technologies. PVU 100, case 500, and/or an associated application can have the ability to use methods of data transmission such as wireless and wired technologies to perform one or more of the functions, capabilities, methods, abilities, etc., described herein. PVU 100, case 500, and/or an associated application can have the ability to use methods of data transmission such as wifi, Bluetooth, cellular, 3G, 4G, near field communication (NFC), or similar for the transmission of data to the users personal digital device. PVU 100, case 500, and/or an associated application can have the ability to use methods of data transmission such as wifi, Bluetooth, cellular, 3G, 4G, near field communication (NFC), or similar for the transmission of data to a network. PVU 100, case 500, and/or an associated application can have the ability to use methods of data transmission such as text messaging or SMS. PVU 100, case 500, and/or an associated application can have the ability to use methods of data transmission such as electronic mail or email. PVU 100, case 500, and/or an associated application can have the ability to use methods of data transmission such as notifications or push notifications to the user's digital device.
PVU 100, case 500, and/or an associated application can have means for user control of the functionality, features, configurations etc. of PVU 100, case 500, and/or an associated application through the use of various features of the application referred to as configurations or settings. These settings can include, but are not limited to exemplary general usage settings listed in Table 1.
Settings can include, but are not limited to device manufacturer data sharing settings listed in Table 2.
Settings can include, but are not limited to user, usage, system, device, and operational data settings listed in Table 3.
Settings can include, but are not limited to software configuration and firmware updating settings listed in Table 4.
Settings can include, but are not limited to healthcare system data sharing settings listed in Table 5.
Settings can include, but are not limited to retailer and/or consumer facing data settings listed in Table 6.
Settings can include, but are not limited to device access settings listed in Table 7.
Settings can include, but are not limited multiple user settings listed in Table 8.
Settings can include, but are not limited to, defined usage profile settings listed in Table 9.
Settings can include, but are not limited to setting related to integration with other applications listed in Table 10.
Settings can include, but are not limited to error code and troubleshooting settings listed in Table 11.
Settings can include, but are not limited to settings related to methods of communication in Table 12.
Heating Element Materials and Application
The heating element may be made using direct writing (DW). The use of direct writing of a conductive metal or conductive material directly to the heating element support member or wire guide(s), or other component performs the function of the heating element(s) that is currently embodied by a metal wire or metal ribbon. This concept expands the material(s) potentially used for the heating element beyond the scope of using a metal wire or metal ribbon. The use of metal deposition methods such as plating, electroplating, or sputtering to effect the same heating element functionality as described throughout the section may be performed through the implementation of direct writing methods. The use of embedded metal into formed ceramic, or similar, components to effect the same function may be used for directly written heating element(s). Likewise, embedded metals may be used to facilitate electrical connection to directly written elements.
In an embodiment, direct writing of a conductive metal or conductive material to a heating element support member or wire guide, or other component which performs the function of a heating element can be used to construct a heating element or wire guide. Direct writing of these conductive materials or metals can be done instead of the metal wire and/or metal ribbon described previously herein. Direct writing expands the materials that can be used for the heating element beyond a metal wire or metal ribbon. In addition, metal deposition methods such as plating, electroplating, or sputtering can be used to make the same heating element and/or contact functionality as described hereinafter as performed through the implementation of direct writing methods. Likewise, the use of embedded metal into formed ceramic, or similar, components can be used to make the heating element and/or contact functionality as described hereinafter as performed through the implementation of direct writing methods. Embedded metals can be used to facilitate electrical connections to directly written elements.
Direct Writing (DW) typically refers to a printing or patterning method that employs a computerized, motion-controlled stage with a motionless pattern generating device to dispense flowable materials in a designed pattern onto a surface. Conductive flowable materials (a.k.a., “inks”) that can be used in direct write applications include, but are not limited to: (i) polymeric-metallic particles in a polymeric matrix, primarily for polymeric substrates Silver, graphite, tungsten, copper; (ii) cermet-metallic particles in a glass matrix, primarily for ceramic substrates, gold, platinum, silver; (iii) nanoparticulate silver; and (iv) specialty electrode materials such as titanium, stainless steel, niobium, and/or titanium nitride.
Substrates (i.e., surfaces) that can be used in DW applications include, but are not limited to ceramics and metal. Examples of suitable ceramics include, but are not limited to: alumina, aluminum nitride, yttria-stabilized zirconia, and pyrex. Examples of suitable metals include, but are not limited to: stainless steels (e.g., 316L, 302, 304 and 430), nitinol, and titanium alloys.
In an embodiment, a heating element is comprised of a conductive (flowable) material deposited on a substrate (support member). By depositing the heating element material on a support member, the heating element is now thermally coupled to the support member through the process of direct writing the heating element directly to the support member. The heating element is created using the process of direct writing can be substantially L-shaped etc., as described herein. For example, direct writing can be used to construct heating elements in place of wires and/or metal clips illustrated in
Taking
The Use of Infra-Red (IR) Reflective and IR Emissive Ceramics
Materials such as certain ceramics, glasses, metals or metal coatings, and minerals such as quartz that have functional properties relating to an intrinsic ability to either be IR reflective, IR emissive, or IR absorptive may be used. These materials may be used to comprise the heating element support member, a sleeve or encasing for the heating element, adjacent wick, and the component of the vaporizer unit that embodies the inner surface of the vaporization chamber. The “vaporization chamber” and “inner surface of the vaporization chamber” are illustrated in
The use of IR reflective material(s) for the heating element may be intended to increase the efficiency of the heating element by directing IR thermal energy away from the heating element support member or wire guide. The use of IR emissive or IR absorptive material(s) for the heating element may be intended to incorporate the heating element support member or wire guide as a part of the heating element where the heating element and heating element support member or wire guide are intended to together serve the function of the heating element. The use of the IR emissive or absorptive material(s) as the support member may allow for the functional “heating element” comprised of both the heating element and the support member to have a larger effective surface area and more uniform transmission of the IR (thermal) energy generated from the heating element. The use of IR emissive material(s) functions to encase, cover, or shield the heating element preventing direct contact of the heating element to the vaporization chamber while still allowing for the transfer of IR thermal energy into the vaporization chamber. The use of IR reflective material(s) for the construction of the component that comprises the inner surface of the vaporization chamber functions to reduce thermal loss and increase the thermal efficiency of the heating element. The inner surface of the component that comprises the inner surface of the vaporization chamber may be coated or treated with material(s) that serves to make the inner surface IR reflective.
IR reflectivity may be the intrinsic property of a material to reflect IR energy as opposed to absorbing, or transmitting the IR energy. In general, for any opaque object, emissivity is the opposite (reciprocal) of reflectivity, and Emissivity+Reflectivity=100% of IR energy. Similarly, for translucent objects, Emissivity+Reflectivity+Transmission=100% of IR energy. Exemplary IR reflective materials that can be used may include: 1) ceramic (certain formulation of macroporous, microporous, and structural Alumina based ceramics are IR reflective); 2) metals (e.g. gold, silver, and aluminum can be used as IR reflectors); 3) dielectrics such as fused silica substrate; 4) specialty layered materials such as alternating layers of polystyrene and tellurium; and 5) combination application(s) such as a gold-coated alumina based ceramic could be utilized to maximize IR reflectivity of the component.
IR emissivity may include the intrinsic property of a material to emit, or transmit IR energy as opposed to absorbing (except where indicated otherwise), or reflecting the IR energy. Examples of IR emissive materials may include ceramic (formulations of macroporous, microporous, and structural alumina based ceramics). Zirconia, Ytria Stabilized Zirconia, and most Alumina Zirconia mixed ceramics are IR emissive or absorptive. Other examples include metals (e.g. steel and titanium are IR emissive or absorptive dependent on the surface roughness and thickness of the metal), sapphire, AL203, zinc selenide, germanium, and/or silicon.
The Use of Viscosity, Temperature, and Velocity/Flow Measurement Sensors
Sensors may be used for the measurement of the viscosity of the liquid solution contained in the cartridge. The sensor(s) may be used for the measurement of the temperature of the liquid solution contained in the cartridge. Likewise, viscosity and temperature sensors may measure the viscosity and temperature of the liquid in the cartridge for the purpose of modulating the activation of the heating element to optimize heating element performance in relation to the temperature and viscosity of the liquid. Performance characteristics of the heating element include time to maximum current input or heating element “warm up”, duration of the time period between activation and maximum current, the time between maximum current and deactivation or heating element “cool down” as well peak electrical current delivered to the heating element and duration of time for peak electrical current delivered to the heating element.
The use of viscosity and temperature sensors for measuring the viscosity and temperature of the liquid in the cartridge may be for the purpose of controlling the activation of the device within an established operating range of temperature and viscosity. Preventing activation of the device under conditions that are below the cut-off range for operation and similarly preventing activation of the device at temperature above cut-off range for activation. The use of viscosity and temperature sensors measuring the viscosity and temperature of the liquid in the cartridge may be for the purpose of preventing misuse or abuse of the device by using the known temperature dependent viscosity of the proprietary liquid formulation used in the device and preventing activation of the device if a liquid used in the device does not comport with the known temperature dependent viscosity of the intended proprietary liquid formulation.
The use of a temperature sensor in the area of the vaporization chamber may be in order to monitor the temperature of the vaporization chamber and relay that temperature data to the PCB/CPU of the device that controls the heating element activation in order to modulate the current flow to the heating element to maintain optimum temperature conditions within the vaporization chamber.
The use of a temperature sensor in the area of the vaporization chamber may be in order to monitor the temperature of the vaporization chamber and relay that temperature data to the PCB/CPU of the device that controls the heating element activation in order to deactivate the device if temperatures above the desired activation range (for example <280° C. for Glycerol based solutions and (<400° C. for propylene Glycol based solutions) of the vaporization chamber are detected. Upon deactivation the device would display an error code using the LED indicator and also transmit the error to the charging case or digital interface (computer, smart phone, tablet or similar) to be relayed to the user through previously described data transferring methods. Note: The desired activation parameters of the device are dependent on the formulation of the liquid and may/should be different secondary to the addition of medications, water, alcohols, or other ingredients added to the preferred liquid formulation.
The use of a temperature sensor(s) in the area of the vaporization chamber may be in order to monitor the temperature of the vaporization chamber and relay that temperature data to the PCB/CPU of the device that controls the heating element activation in order to deactivate the device if the heating element is not capable, due to malfunction, to achieve the desired temperature range to achieve vaporization/volatilization/atomization of the liquid. Upon deactivation the device would display an error code using the LED indicator and also transmit the error to the charging case, or other digital interface (computer, smart phone, tablet or similar) to be relayed to the user through previously described data transferring methods.
A method for preventing the degradation/conversion of glycerol to acrolein (when producing a vapor from glycerol through the application of heat) may be through the use of a temperature sensor in the area of the vaporization chamber in order to monitor the temperature of the vaporization chamber and relay that temperature data to the PCB/CPU of the device that controls the heating element activation in order to deactivate the device if temperatures in the vaporization chamber are reaching temperatures required to convert glycerol to acrolein (<280° C.).
Exemplary temperature sensors may include resistance thermometers. Resistance thermometers may also be called resistance temperature detectors (RTDs). Examples include carbon resistor elements, strain free elements, thin film elements, wire-wound elements, and/or coiled elements.
There may be a viscosity sensor that is also used. For example, a micro viscometers such as a process viscosity sensor can be designed or configured in conjunction with an RTD.
There may be a velocity or flow sensor that is also used. For example, an RTD based flow or velocity sensor may include a constant temperature anemometer or thermal anemometer.
In alternative embodiments, there may be thermal mass flow sensors that are similar to RTD based sensors utilizing heat transfer principles to determine the flow velocity of a fluid. As fluid passes across the sensor, heat is carried from the sensor to the medium. This relationship is dependent upon the flow rate. As flow increases, so does the amount of heat that is transferred. By knowing the temperature of the medium, the flow rate can be determined from the amount of voltage compensation needed to maintain a constant temperature differential.
In alternative embodiments, there may be Mass airflow sensor (MAF). The MAF may include a micro-bridge mass airflow sensor, a MEMS thermal flow sensor, or a hot wire mass airflow sensor similar to a hot wire anemometer. Alternatively, a vane meter sensor also referred to as a VAF (volume air flow) sensor may be used. A membrane MAF is a technology that utilizes a very thin electronic membrane placed in the air stream. The membrane has a thin film temperature sensor printed on the upstream side, and one on the downstream side. A heater is integrated in the center of the membrane which maintains a constant temperature similar to the hot-wire approach. Without any airflow, the temperature profile across the membrane is uniform. When air flows across the membrane, the upstream side cools differently from the downstream side. The difference between the upstream and downstream temperature indicates the mass airflow.
The Use of Temperature, and Velocity Measurement Sensors to Perform Some Types of Lung Function or Pulmonary Function Testing and Spirometry
A spirometer or similar respiratory testing device may be used in testing lung and airway capacity or function of a patient and/or for measuring the amount or volume and/or speed or flow of air that can be inhaled and/or exhaled by the patient. More particularly, the present relates to a portable, lightweight, hand-held spirometer particularly suitable for home and personal use, although equally capable of being used in hospitals, doctor's offices, and like institutions. The present is also directed to a system, software, and method for obtaining, storing, and displaying the results of spirometry tests. In general, a spirometry test measures the air entering and leaving the lungs and airways and is often used as a preliminary test for assessing the health condition of a patient's lungs and airways as well as a means for periodically tracking the progress of disease treatment and effect of medication. The spirometry test typically is performed using a device known as a spirometer, and the data provided by the test often is provided graphically in the form of a “volume-time curve” in which volume in liters is shown along the Y-axis and time in seconds is shown along the X-axis and/or in the form of a “flow-volume loop” in which the rate of airflow is shown on the Y-axis and the total volume inspired or expired is shown on the X-axis.
By way of example, a few common parameters that may be measured during respiratory testing include: Forced Vital Capacity (FVC) which is the total volume of air that can be forcibly blown out after full inspiration; Forced Expiratory Volume (FEV) at timed intervals (for instance, at 1.0 second (FEV1)); Forced Expiratory Flow (FEF) which is the average flow (speed) of air coming out of the lungs and airways during a specified period of the expiration; and Peak Expiratory Flow (PEF) which is the maximum flow (speed) of air during maximum expiration initiated after full inspiration. These parameters often are provided in raw data form (i.e., in liters, liters/second, liters/minute, etc.) and as a percentage of a predicted value (i.e., a percent of a predicted value for a patient of similar age, height, weight, gender and ethnicity).
Each test typically is repeated three times to ensure reproducibility. The obtained results of the tests are highly dependent on patient cooperation and effort. For meaningful and valid test results to be obtained, the patient should provide vigorous and maximum respiratory effort for full expiration and/or inhalation. Typically, if the test is given during an office visit or at a hospital or the like, the patient should be coached and motivated by the attending nurse, physician, or technician to keep exhaling as hard as possible for a predetermined period of time (i.e. “keep going, don't stop”). However, no such assistance is typically provided during home use of a spirometer. Hence, the obtained home test results may not necessarily be valid if maximal effort is not provided throughout the duration of full expiration or inhalation.
The tests or functions may include:
As described, a spirometer is an instrument for measuring the air capacity of the lungs. Spirometry is a type of pulmonary function test that measures the amount of air taken in (volume) and exhaled as a function of time. Spirometry is generally the first and most commonly done lung function test. Pulmonary function tests are a group of tests that measure how well the lungs take in and release air and how well they move gases such as oxygen from the atmosphere into the body's circulation. The pulmonary function tests may relate how well the taking in and release of air are performed and are not related to pulmonary function tests as they relate to gas exchange, for example the movement of gases such oxygen from the atmosphere to the body's circulation.
The most common parameters measured in spirometry may include:
There are different types of pressure transducers that can be used that include force collector types. These types of electronic pressure sensors generally use a force collector (such as a diaphragm, piston, bourdon tube, or bellows) to measure strain (or deflection) due to applied force (pressure) over an area, such as:
Other types of electronic pressure sensors may include types of electronic pressure sensors that use other properties (such as density) to infer pressure of a gas, or liquid. For example, the types may include:
The functionality of the vaporizer may be expanded to include the functionality of a spirometer for the purpose of performing lung or pulmonary function testing and the utilization of that data to measure improvement in lung function over time and to optimize the performance of the vaporizer for the individual user based on their lung function as determined through spirometry and pulmonary compliance testing.
A digital interface cartridge may be located where a wick element for directly contacting a liquid to be changed into a vapor is replaced by the user.
New or Spent Cartridge Recognition and Vaporizer Activation, Cartridge Content Recognition and Vaporizer Activation, Cartridge Content and Usage Data Gathering
An electromechanical interface connections may be used between the cartridge and the atomizer. The electromechanical interface connection may convey a resistance measurement from the cartridge to the device. The resistance measurement conveyed from the cartridge to the device may serve as a requirement for the device to be activated. The resistance measurement conveyed from the cartridge to the device may serve to modulate the activation parameters of device, such as peak activation temperature, to optimize the vaporization of the fluid contained in the cartridge. The use of a seal on the cartridge that has a contact surface may be used for interfacing with the atomizer housing and convey that the cartridge seal is intact. Likewise, a seal on the cartridge that is conductive may be used such that when intact it completes a circuit by bridging two contact points in the puncturing element of the atomizer housing. The use of a seal on the cartridge that is conductive and when intact completes a circuit by bridging two contact points in the puncturing element of the atomizer housing may be used such that the completed circuit constitutes a signal to the device that the cartridge is new and unused. The device being rendered inactive if contact surface on the cartridge is not recognized by the interface with the atomizer as being intact.
The use of an electromechanical interface connections and resistance measurements may effect a one-time-use configuration such that once a cartridge is inserted into the device and used it cannot be refilled and reused by the user for subsequent use in the vaporizer. The use of a fuse wire or “fused element” in the cartridge may prevent reuse of the cartridge by the user. A fused element may be used in the cartridge such that when a “dry wick” is detected which corresponds the content of the cartridge being entirely consumed the fuse is energized in such a way to melt the fuse wire and render the cartridge inactive. The device may be rendered inactive when an inactive cartridge is present in the device.
The cartridge may have an internal contact positioned such that it is in contact with the outer lateral surface of the atomizer when the cartridge is fully inserted into the device. The cartridge may have an internal contact positioned such that it is in contact with the outer lateral surface of the atomizer when the cartridge is fully inserted into the device that serves to complete a circuit by bridging two contact points on the opposing lateral surface of the atomizer housing. The cartridge may have an internal contact positioned such that it is in contact with the outer lateral surface of the atomizer when the cartridge is fully inserted into the device that serves to complete a circuit by bridging two contact points on the opposing lateral surface of the atomizer housing. The completion of the circuit serves as a signal that the cartridge is fully inserted. The internal contact may be a fuse element or wire. The cartridge may have an internal contact positioned such that it is in contact with the outer lateral surface of the atomizer when the cartridge is fully inserted into the device that serves to complete a circuit by bridging two contact points on the opposing lateral surface of the atomizer housing. The internal contact may be a fuse element or wire and if the element or wire is melted then the cartridge is inactive or used and should not be able to be used again if refilled or reinserted into the device.
The cartridge may have an internal contact positioned such that it is in contact with the outer lateral surface of the atomizer when the cartridge is fully inserted into the device that serves to complete a circuit by bridging two contact points on the opposing lateral surface of the atomizer housing. Where the internal contact is a fuse element or wire. Where the atomizer housing that is in contact with internal contact has at least two different circuits that are arranged proximal to distal such that as the cartridge is inserted it activates the distal circuit first and the proximal circuit when fully inserted. Similarly when the cartridge is removed the proximal circuit is broken (no longer electrical coupled) and the distal circuit is activated as the cartridge is removed.
The cartridge may have an internal contact positioned such that it is in contact with the outer lateral surface of the atomizer when the cartridge is fully inserted into the device that serves to complete a circuit by bridging two contact points on the opposing lateral surface of the atomizer housing. Where the internal contact is a fuse element or wire. Where the atomizer housing that is in contact with internal contact has at least two different circuits that are arranged proximal to distal such that as the cartridge is inserted it activates the distal circuit first and the proximal circuit when fully inserted. Similarly when the cartridge is removed the proximal circuit is broken (no longer electrical coupled) and the distal circuit is activated as the cartridge is removed. Where the activation of the distal circuit on removal of the cartridge energized the fuse element or wire in order to melt the element or wire. Exemplary types of fuse elements or fuse wire may include Zinc, Copper, Silver, Aluminum, or Alloys.
The device may have a two stage process to recognize that a cartridge is new and sealed when inserted into the device, with the first stage being the contact surface on the seal of the cartridge, and the second stage being the internal contact such that each contact should be made sequentially e.g. the cartridge seal contact should be followed by the internal cartridge contact in order for the device to be rendered active and ready for use, if the two stage contact is not made e.g. only the internal contact is made (as would be the case in an already used cartridge being reinserted) then the device is rendered inactive.
The device may register a process where the cartridge is inserted to the point of contact of the seal with the puncturing element of the atomizer housing, then the cartridge makes contact with the internal contact and atomizer in the fully inserted or seated portion, and finally the third step of the process where the internal contact is “broken” i.e. no longer in direct physical contact with the distal lateral surface of the atomizer upon removal of the cartridge. This process at completion renders the device inactive until steps one and two are repeated with a new cartridge. The device may recognize the cartridge cycles such that activation cycle data in terms of number and duration of activations per cartridge can be gathered. The use of a resistance value from the cartridge to atomizer housing contacts to relate “cartridge type” or “cartridge content(s)” date to the vaporizer.
The utilizing of cartridge use cycles and the cartridge content may be used to calculate per inhalation and per cartridge dose delivery of active component to the user. The storage, extrapolation, transfer or transmission of the data gathered by the cartridge device interface may be used. The contacts on the external surface of the vaporizer may be used to interface with contacts on the internal surface of the light pipe sleeve. The use of contacts on the external surface of the vaporizer may interface with contacts on the internal surface of the light pipe sleeve. The most distal external contact is coupled to the cartridge seal and when the seal is broken the contact is no longer electrically coupled.
The use of contacts on the external surface of the vaporizer may interface with contacts on the internal surface of the light pipe sleeve. The most distal external contact is coupled to the cartridge seal and when the seal is broken the contact is no longer coupled. A cartridge that has a punctured seal and the proximal contact is no longer coupled to the seal the cartridge is determined to have been used. The use of the external contacts described above may be used to perform a process of cartridge recognition such that a stepwise process activates a series of circuits as the cartridge is inserted or removed.
The use of the external contacts may perform a process of cartridge recognition such that a stepwise process activates a series of circuits as the cartridge is inserted or removed such that if the cartridge is removed, activated the described series of circuits prior to a certain number of activations, or prior to a “dry wick” indication signaling the cartridge contents have been consumed the device is rendered inactive until another cartridge completes the insertion process with an intact proximal contact. A set of features on the cartridge may correspond to features on the light pipe sleeve that serve to align the cartridge for insertion into the device such that the cartridge should be “clocked” with the light pipe sleeve so that it can be inserted into the device and if the cartridge is not clocked or aligned with the light pipe sleeve the cartridge cannot be inserted. Cartridge recognition may prevent insertion and use of the “wrong” cartridge not containing the intended active component or component dosage.
The functionality of the vaporizer may include functions to prevent misuse or abuse of the vaporizer by preventing the reuse of spent cartridges, prevent the refilling of cartridges with different fluids not intended by the manufacturer, or adding ingredients to a sealed cartridge. This may apply to the ability of the device to recognize the contents of the cartridge and the storage of that data to be used in extrapolating per inhalation and per cartridge dosing information, furthermore the cartridge content/formulation data can be used to optimize the activation of the device in terms of peak operating temperature, and time to peak operating temperature. A wick element for directly contacting a liquid to be changed into a vapor now contains contact element to interface with contact element on the liquid cartridge.
Liquid pH Measurement and Vaporizer Activation and Control
A pH measurement sensor may be used to sample the cartridge fluid and convey pH of measured fluid to onboard PCB/CPU and software interface. The device may be deactivated if the pH of the sampled fluid does not fall within the specified range of pH for the intended fluid. The pH values of the liquid may be used to convey formulation and active component/drug data to the onboard PCB/CPU and software interface. The pH values of the liquid may be used to convey formulation and active component/drug data to the onboard PCB/CPU and software interface to optimize the heating element activation to optimize device performance for the formulation.
There are several types of pH sensors that may be used. Several different modalities of small form or “micro” or “mini” pH sensors/probes may be used. For example, the sensors may include: 1) non-invasive pH sensors, sometimes referred to a “sensor” spots transmits data to a fiber optic receiver; 2) flow through cell (FTC) also called flow through pH minsensors; or pH Microsensors which are miniaturized pH sensors designed for measuring in small volumes and high spatial resolution. The sensor tip is typically below 150 The sensors are normally based on a 140 μm silica fiber which enables integration into a manifold of small scale environments. These sensors do not require reference electrodes and there is no leakage of electrolytes, a clear advantage over common electrodes. Alternatively, there may be various electrochemical methods or non-electrochemical methods such as catalytic, calorimetric, and optodes for sensing pH.
The methods of activation and controlling the activation of the device may include expanding the mechanisms for controlling the activation of the device through the measurement of the pH of the liquid and methods for preventing the misuse or abuse of the device by preventing the use of nonproprietary liquids. Additionally this may be used for the identification of the liquid in relation to formulation. A wick element that is used for directly contacting a liquid to be changed into a vapor may include a pH sensor assembly.
The Use of Light Emitter and Light Sensor in Conjunction with a Turbine for Determining Flow Velocity and Volume, Unique User Inhalation Signature, and Device Control
The assembly may include an emitter and sensor with a turbine positioned in between such that the beam is temporarily interrupted by the turbine vane(s) when rotating. The positioning of the assembly in the flow path of the device may be such that airflow through the device passes through the turbine impacting the vanes and causing the turbine to rotate. The interruption of the beam by the turbine vane may be a static signal when the turbine is not rotating, or pulse signal when the turbine is rotating. The pulse signal may be used to activate the device. The beam interruption frequency may correlate with the airflow velocity through the turbine. The turbine vane(s) may have a leading edge that initiates the interruption of the beam and a trailing edge that once passed the path of the beam the interruption of the beam ends. The device when under operation may have a pulse signal from the turbine vane interruption of the beam being recognized as a “normal operation” signal. The device is deactivated when activated through existing conductive methods (described in existing filings) and the pulse signal in not present. The flow velocity determines flow volume and subsequently determine per inhalation dose delivery of active compound.
This may be used to prevent overuse or abuse of the active compound being delivered by the device through the deactivation of the device if the maximum intended dose over time has been delivered to the user by the device. The flow velocity is used to modulate the activation parameters of the heating element such that heating element energizing is correlated to flow velocity. A pulse signal may determine time or duration of inhalation and pulse signal frequency and duration determines the inhalation signature of the specific user. The use of the inhalation signature of the user can prevent unauthorized use of the device by an unintended user by deactivating the device if the unique inhalation signature does not match the unique inhalation signature of the intended user.
Preventing the Reuse of the Liquid Cartridge in the Vaporizer.
In one embodiment, there may be a “one time use” liquid cartridge. The use of one, two, or a plurality of directional blades may slice, cut, or transect the liquid cartridge upon removal of the cartridge by the user. The directional blade(s) may be positioned in the light pipe of the device, which serves as the receiving component for the liquid cartridge. The use of a rod, pin, or similar may serve as the axis of the blade allowing for the blade to rotate about the axis. The rotation blade(s) may be shaped such that there is a limit to the rotation in the fully extended position such that the blade(s) should not be able to rotate further than the fully extended position. A spring may be positioned about the blade axis to assist the positional rotation of the blade. The blade may be designed such that there are ridges, teeth, grooves, or similar designed to facilitate the rotation of the blade into the cutting position when the cartridge is being removed from the device.
The rotation blade may have multiple positions: a) fully depressed during the cartridge insertion and while the cartridge remains fully inserted; b) the fully extended cutting position where the blade is substantially orthogonal to the long axis of the cartridge such that the blade is extended and able to transect, cut, slice or similar the wall(s) of the cartridge; c) a transient position which is the range of rotation about the axis between the fully depressed and the fully extended position. The cartridge may be sliced, or cut, in such a fashion that there is a cut or cuts that fully divide the wall(s) of the cartridge for the majority of the length of the cartridge (distal to proximal) preventing the cartridge from serving as a reservoir or container for liquid.
Directional blade(s) may be used such that the distal aspect of the blade is non-cutting such that the cartridge can be inserted into the device without being cut. The cartridge may be wholly or partially comprised of a plastic, polymer, or similar that is readily dividable, or easily cut or sliced, or similar to facilitate the use of the cutting blades. The cartridge may be wholly or partially comprised of a plastic, polymer, or similar that is readily able to be punctured, pierced or similar by a sharp object such as a sharp point, blade edge or similar. The cartridge may be wholly or partially comprised of a plastic, polymer, or similar that when cut, sliced, or similar does not maintain the shape or geometry of the cartridge prior to being cut. For example the proximal aspect of the cartridge would flare outward thus increasing the outer diameter of the cartridge such to prevent reinsertion of the cartridge into the light pipe sleeve.
The cartridge once removed may be rendered unusable, as the cartridge should no longer be capable of containing fluid such that the cut(s) or slice(s) provide a means for fluid to escape the cartridge if the cartridge was refilled. The rotational blade(s) and cartridge may be used to effect a “one time use” cartridge configuration. The prevention of reuse, misuse, or abuse of the device where the one time use cartridge should not be able to be refilled or reinserted into the device. Rotational blades may be used in conjunction with cartridge recognition methods described above. The rotation blades may serve as a means to prevent cartridge reuse, misuse, or abuse by rendering cartridge recognition methods, described in detail above, unusable upon removal of the cartridge.
The use of the described directional features on the distal aspect of the rotational blades may prevent unwanted, unintended, or accidental displacement or removal of the cartridge from the device once inserted. The cartridge in the device may be engaged securely through the use of directional features on the rotational blade(s) or similar component that allow for the cartridge to be inserted into the device using less force than required to remove the cartridge as the removal of the cartridge involves the interfacing of the outer wall of the cartridge lateral surface being in contact with the directional features of the rotation blade(s) or similar component.
Methods for Reducing or Mitigating the Risk of Choking on Vaporizer Components, Choking Risk Reduction Packaging of Vaporizer Cartridge and Vaporizer Cartridge Assemblies
The Consumer Product Safety Commission states any toy that is small enough to fit through a circle an inch and a half in diameter (the size of a toilet paper tube) or is less than two and a quarter inches long is unsafe for small children. Packaging for the user removable and user replaceable cartridge may be designed to reduce the risk of choking by providing a packaging such that at least one dimension is greater in length of 2.25 inches. The use of packaging for the user removable and user replaceable cartridge or cartridge assembly (“upper removable assembly”) may be designed to reduce the risk of choking by providing a packaging such that at least one dimension is greater in length of 2.25 inches.
The use or application of packaging for the liquid cartridge, liquid cartridge assembly, or upper removable assembly may be designed and intended to be sized and shaped in such a manner that the risk of the liquid cartridge, liquid cartridge assembly, or upper removable assembly (when combined with the packaging wholly, substantially, or similarly) reduces the risk of being a choking hazard. Additionally the force applied by the user to remove the liquid cartridge, liquid cartridge assembly, or upper removable assembly from the packaging and or the dexterity needed for removing the liquid cartridge, liquid cartridge assembly, or upper removable assembly from the packaging may be intended to be such that these maneuvers would be difficult for a young child to perform as a means to further reduce the risk or potential hazard or similar of the liquid cartridge, liquid cartridge assembly, or upper removable assembly being a choking hazard.
When the packaging for the cartridge or cartridge assembly or upper removable assembly is a strip or substantially flat member or similar of paper, plastic, cardboard, or similar with one or more surface(s) having an adhesive component, then the strip or substantially flat member or similar such that the overall length greater than 5.5 inches which is folded along the midline of the length such that the length of the strip or substantially flat member or similar is greater than 2.25 inches when folded with the cartridge or cartridge assembly or upper removable assembly or upper removable assembly is positioned in the center of the folded strip or substantially flat member or similar such that it is in between the folded strip or substantially flat member or similar elements or similar. When the packaging for the cartridge or cartridge assembly or upper removable assembly is a strip or substantially flat member or similar of paper, plastic, cardboard, or similar with one or more surface(s) having an adhesive component, then the strip or substantially flat member or similar such that the overall length greater than 5.5 inches which is folded along the midline of the length such that the length of the strip or substantially flat member or similar is greater than 2.25 inches when folded with the cartridge or cartridge assembly or upper removable assembly is positioned in the center of the folded strip or substantially flat member or similar such that it is in between the folded strip or substantially flat member or similar and the user would peel the ends of the strip or substantially flat member or similar to overcome the adhesive bond between the folded surface to free the cartridge or cartridge assembly or upper removable assembly from the strip or substantially flat member or similar packaging for use in the device.
When the packaging for the cartridge or cartridge assembly or upper removable assembly is a strip or substantially flat member or similar of paper, plastic, cardboard, or similar with one or more surface(s) having an adhesive component, then the strip or substantially flat member or similar such that the overall length greater than 2.25 inches and cartridge or cartridge assembly or upper removable assembly is positioned and held in place the center of the strip or substantially flat member or similar. When the packaging for the cartridge or cartridge assembly or upper removable assembly is a strip or substantially flat member or similar of paper, plastic, cardboard, or similar with one or more surface(s) having an adhesive component, then the strip or substantially flat member or similar such that the overall length greater than 2.25 inches and cartridge or cartridge assembly or upper removable assembly is positioned and held in place the center of the strip or substantially flat member or similar where the user must remove the cartridge or cartridge assembly or upper removable assembly from the strip or substantially flat member or similar packaging for use in the device. When the packaging for the cartridge or cartridge assembly or upper removable assembly is a molded or similarly formed plastic strip or substantially flat member or similar with an overall length greater than 2.25 inches, then the plastic strip or substantially flat member or similar having a feature, element, or similar that is substantially circular or “C” shaped in such a manner to trap, position, or otherwise hold the cartridge or cartridge assembly or upper removable assembly in place at a point along the length of the stip.
When the packaging for the cartridge or cartridge assembly or upper removable assembly is a molded or similarly formed plastic strip or substantially flat member or similar with an overall length greater than 2.25 inches, then the plastic strip or substantially flat member or similar having a feature, element, or similar that is substantially circular shape in such a manner to trap, position, or otherwise hold the cartridge or cartridge assembly or upper removable assembly in place at a point along the length of the strip or substantially flat member or similar where the feature being substantially circular the user would pull the cartridge or cartridge assembly or upper removable assembly to remove the cartridge or cartridge assembly or upper removable assembly from the circular portion of the packaging for use in the device. When the packaging for the cartridge or cartridge assembly or upper removable assembly is a molded or similarly formed plastic strip or substantially flat member or similar with an overall length greater than 2.25 inches and the plastic strip or substantially flat member or similar having a feature, element, or similar that is substantially “C” shaped in such a manner to trap, position, or otherwise hold the cartridge or cartridge assembly or upper removable assembly in place at a point along the length of the strip or substantially flat member or similar where the feature being substantially C shaped the user would pull or pry or similar the cartridge or cartridge assembly or upper removable assembly to remove the cartridge or cartridge assembly or upper removable assembly from the packaging.
The packaging may have one or a plurality of surfaces where instructions for the user relating to how to remove the packaging from the cartridge or cartridge assembly or upper removable assembly from the packaging may be printed, imbedded, etched or similar. The packaging may have one or a plurality of surfaces where information relating to the cartridge contents, expiration or “best if used by” date, warnings, ingredient information or similar may be printed, imbedded, etched or similar. The packaging may have one or a plurality of surfaces where information relating to reducing the risk of choking by leaving the cartridge or cartridge assembly or upper removable assembly in the packaging until the user is ready to place the cartridge in the vaporizer, or similar, may be printed, imbedded, etched or similar.
The packaging for a new unused cartridge or cartridge assembly or upper removable assembly is reusable such that a spent or used cartridge may be placed in the packaging such that a used or spent cartridge or cartridge assembly or upper removable assembly would be held in the packaging in the same fashion or manner or similar as an unused cartridge or cartridge assembly or upper removable assembly to reduce the risk of choking on a spent or used cartridge or cartridge assembly or upper removable assembly. The packaging may have one or a plurality of surfaces where information relating to reducing the risk of choking by placing the used or spent cartridge or cartridge assembly or upper removable assembly into the packaging prior to disposal, recycling or similar, may be printed, imbedded, etched or similar. The packaging containing the cartridge or cartridge assembly or upper removable assembly may require a degree of dexterity to remove the cartridge or cartridge assembly or upper removable assembly from the packaging such as to make the removal of the cartridge or cartridge assembly or upper removable assembly difficult for a child to perform. The packaging containing the cartridge or cartridge assembly or upper removable assembly may require a degree of force to remove the cartridge or cartridge assembly or upper removable assembly from the packaging such as to make the removal of the cartridge or cartridge assembly or upper removable assembly difficult for a child to perform. The packaging material may be resistant to moisture such that the packaging will not degrade, or lose shape, form, structure, or similar if exposed to a moist or wet environment. The packaging material may be resistant to moisture such that the packaging will not degrade, or lose shape, form, structure, or similar if exposed to a moist or wet environment such as the oral cavity of a child.
The cartridge in a cartridge assembly embodiment may include at least the cartridge and a proximal wick that serves to transfer, transport, or similarly deliver the liquid or gel material from the cartridge to the heating element or elements. The proximal wick may serve to transfer, transport, or similarly deliver the liquid or gel material to a distal wick that may be fluidly coupled to the heating element(s) or be in close proximity to the heating element. The proximal wick may use passive diffusion, active diffusion, capillary action, or similar to deliver the liquid or gel material to the heating element(s). The distal wick or the proximal wick, or the distal wick and proximal wick may together in sequence or simultaneously or independently serve to deliver aerosolized droplets from the wick element to the heating elements, or to within close proximity of the heating element(s) such that the heating element may vaporize, volatize, or further aerosolize the liquid or gel material for the purpose of generating an inhalable vapor or aerosol. The proximal wick may also function as support structure, lattice, substrate, stabilization member, positioning element, scaffold or similar for the heating element(s). The heating element(s) may be etched, plated, deposited, sputtered, directly written, or otherwise deposited, or applied on the proximal wick. The proximal wick may be a functional part of the heating element(s) such that thermal energy from the heating element is absorbed, emitted, reflected, or transferred to the proximal wick from the heating element(s). The heating element(s) may be connected to a microprocessor that serves to control, manage, modulate, regulate, monitor, cycle, or otherwise mediate, control or similar the activation of the heating element(s). In some embodiments, the heating element may be comprised a metal wire or coil, metal ribbon, a resistive element(s), a Microheater(s), a MEMS style Microheater(s), infrared (IR) emitter(s), grey body emitter(s), or similar.
The cartridge assembly thus may include the cartridge, liquid or gel material and medicament, distal wick, proximal wick, heating element(s), microprocessor(s), PCB(s), and an interface or similar type connector(s) to link the cartridge assembly to the main PVU component(s) which consist primarily of the remaining elements and components, such as those not described previously as being a part of the cartridge assembly as illustrated in
The connector may be a threaded type connection, a latching type interface, a magnetic or electromagnetic connection such that the cartridge assembly has a magnetic or electromagnetic that is of opposite polarity as the magnet or electromagnet connector on the main PVU and the magnetic attraction serves to engage and establish the interface, the connector may be a male female type data connection such as USB or similar. The connector may comprise components for delivering electrical energy from the battery. The connector may include a connection or interface that serve to transfer, gather, or transmit data between the cartridge assembly and the PVU.
The cartridge assembly may be a consumable, or disposable assembly that once the liquid or gel material is consumed the assembly is removed and replaced by the user. The cartridge or cartridge assembly in a generally cylindrical embodiment (shown) is inserted into the distal end of the main PVU where the light transmitting sleeve is comprised such that the inner diameter of the light transmitting sleeve is in close tolerance to the outer diameter of the cartridge such as to effect a wholly, or partially airtight interface.
The cartridge may have one or a plurality of geometric features to allow for one or a plurality of void(s), galley(s), channel(s), or similar to allow for airflow to enter and travel down the feature(s) in between the outer surface of the cartridge and the inner surface of the light transmitting sleeve. In the cylindrical embodiment this may be as the circular diameter of the cartridge having one or a plurality of geometries such that part of the circular shape is removed and replace by a linear line where the removal of the portion of the circular shape results in a void space when the cylindrical element of the cartridge is inserted in to the tubular light transmitting sleeve (e.g.
The alteration of a geometric feature or features of the cartridge outer diameter or dimension allows for control of the amount of airflow that may be drawn into the PVU by the user through the suction, or vacuum pressure, generated during inhalation. The airflow may be limited, restricted, of otherwise mediated through the modification of the geometries of the outer surface of the cartridge and inner surface of the light transmitting sleeve. It may be desirable to modify, mediate, or set the resistance of the device during inhalation, in one embodiment the draw resistance of the PVU would match the draw resistance of a typical smoking article such as a cigarette. In one embodiment, the airflow that flows into the device may be controlled such that it displaces the fluid from the distal wick, or the distal wick and proximal wick such that the air flow travels down the space between the outer surface of the cartridge and inner surface of the light transmitting sleeve and then is forced into the air intake port of the atomizer housing, once the airflow enters the atomizer housing it must passed through liquid or gel saturated wick material, such as a porous ceramic where the liquid or gel in the porous ceramic is forced as droplets or micro-droplets or as an aerosol of droplets or micro-droplets of the approximate size of the pores of the ceramic onto or in close proximity of the heating element to be vaporized.
In some embodiments, for optimal PVU operation there may be an adjustment of the amount of allowable airflow to be correlated to the type of liquid or gel material being used in the vaporizer. Less airflow may be desirable for highly viscous or gel type materials and greater airflow may be desirable for less viscous and more liquid type material. As more liquid materials will diffuse more rapidly, or be more actively transported though capillary action by and through the wick material such that having a greater allowable airflow results in greater delivery of liquid material to the heating element or heating element proximity. Conversely, as more viscous or gel type material does not diffuse as rapidly as less viscous material and does not transfer by capillary action as quickly as less viscous material resultantly it would be desirable in order to effect optimal activation of the PVU to reduce the airflow such that the airflow is metered to account for the slower rate of transport of the more viscous or gel type material by diffusion or capillary action. This may allow for the metering of the airflow to corresponded the amount of fluid displaced from the wick or wicks such that am optimal fluid to air ratio is achieved to allow for optimal vaporization, volatilization, or aerosolization of the material for inhalation by the user. In another embodiment, the air intake fluid displacement ratio may be modulated, adjusted, configured such as to achieve a desirable particle size for the inhalation product (e.g. 1-3 micron, 3-5, micron, 3-10 micron, 5-10 micron, 5-15 micron, 10-20 micron, or greater then 15 micron, or greater then 20 micron particle size, or range of particle sizes, or similar) to achieve pulmonary delivery of the active compound or medicament(s), to the pulmonary vasculature, or to the oral pharyngeal mucosa, or to selectively the pulmonary vasculature and the oral pharyngeal mucosa or to both the pulmonary vasculature and the oral pharyngeal mucosa. In such an embodiment it may be desirable to deliver liquid components that have a flavor component to the oral mucosa such that the particles interact with the taste receptors on the user's tongue. In another embodiment, it may be desirable to deliver the medicament or active component to the oral mucosa or oral pharyngeal mucosa for slower systemic absorption or absorption than absorption or absorption achieved through the more rapid systemic absorption or absorption achieved by pulmonary deliver of the medicament(s). In another embodiment, it may be desirable to deliver the medicament to the pulmonary vasculature (e.g. nicotine to replicate the pharmacodynamics of nicotine delivered by smoking tobacco).
Additionally, the light transmitting sleeve is positioned such that the proximal aspect of the light transmitting component is in contact or close proximity with a light emitting diode (LED) or LED array such that light from the LED is transferred, transmitted, or conveyed from the LED to the light transmitting sleeve. The light transmitting sleeve may be configured to be in proximity to the cartridge, or cartridge element of the cartridge assembly such that light is transferred, transmitted, or conveyed to the cartridge. This allows for the light transmitting sleeve and cartridge to send visual indicators to the user. Visual indicators may include indicators of device activation, cartridge status such as an empty cartridge or new cartridge or cartridge status in the range of either being new and fully or partially consumed, cartridge or cartridge assembly recognition such that the cartridge or cartridge assembly is recognized as being the correct cartridge, battery or capacitor or battery and capacitor status, charging status, remaining activation cycles, reminder notifications, device error(s), and similar.
Following vaporization, volatilization, or aerosolization, collectively referred to in this paragraph as the “vapor” of the liquid or gel type material by the heating element airflow generated by the user forces the vapor out of the atomizer housing and related area of the heating element and proximal wick through a flow galley, or galleys, that serve as the aspiration tube. This area of the device may be the space between the outer diameter or the surface of the battery and the inner surface or diameter of the main body of the PVU. In one embodiment, the battery is encapsulated, shielded, encased, or otherwise isolated from the aspiration tube such that the vapor and airflow though the device does not come into contact with the battery or capacitor directly. The vapor and airflow then passes through the mouthpiece to the user for inhalation.
The middle embodiment of
The bottom embodiment in
The case in one embodiment has an external LED or similar light source for indication case status such as charging, discharging, data transfer, or similar (shown). The case may have an interior storage for PVU accessories such as mouthpieces and spare cartridges or cartridge assemblies. The case may be designed such that a part or the whole of the distal aspect of the contained PVU(s) are visible such that the charging status, or other device status, of the PVU(s) as indicated by the distal LED in the case can be visualized by the user without having to open the case. The case may be designed to be pocket friendly with a convex top surface containing the LED indicator and a partially concave bottom surface (not shown) to optimize the case for being pocket friendly. In another embodiment the case may approximate dimensions to a pack of 20 “100” length cigarettes.
The above description and associated figures teach the best mode of the invention. The following claims specify the scope of the invention. Note that some aspects of the best mode may not fall within the scope of the invention as specified by the claims. Those skilled in the art will appreciate that the features described above can be combined in various ways to form multiple variations of the invention. As a result, the invention is not limited to the specific embodiments described above, but only by the following claims and their equivalents.
This application is a continuation of U.S. patent application Ser. No. 16/010,932, filed on Jun. 18, 2019, which claims priority as a continuation-in-part to U.S. patent application Ser. No. 14/701,046, entitled “VAPORIZER RELATED SYSTEMS, METHODS, AND APPARATUS,” filed on Apr. 30, 2015, which claims priority to U.S. Provisional Application No. 61/987,005, entitled “VAPORIZER RELATED SYSTEMS, METHODS, AND APPARATUS,” filed on May 1, 2014, and which claims priority as a continuation-in-part to U.S. patent application Ser. No. 14/279,174, entitled “SOLDERLESS DIRECTLY WRITTEN HEATING ELEMENTS,” filed on May 15, 2014, which is a continuation-in-part to U.S. patent application Ser. No. 13/698,020, entitled “SOLDERLESS PERSONAL VAPORIZING INHALER,” filed Nov. 14, 2012, now U.S. Pat. No. 9,259,035, which is a continuation-in-part of the following U.S. applications filed on May 15, 2010: U.S. application Ser. No. 12/780,871, entitled “PERSONAL VAPORIZING INHALER WITH MOUTHPIECE COVER”, U.S. application Ser. No. 12/780,872, entitled “ACTIVATION TRIGGER FOR A PERSONAL VAPORIZING INHALER”, now U.S. Pat. No. 8,746,240; U.S. application Ser. No. 12/780,873, entitled “PERSONAL VAPORIZING INHALER CARTRIDGE,” now U.S. Pat. No. 9,861,772; U.S. application Ser. No. 12/780,874, entitled “ATOMIZER-VAPORIZER FOR A PERSONAL VAPORIZING INHALER”, now U.S. Pat. No. 8,550,068; U.S. application Ser. No. 12/780,875, entitled “PERSONAL VAPORIZING INHALER WITH INTERNAL LIGHT SOURCE,” filed May 15, 2010, now U.S. Pat. No. 8,757,147; U.S. application Ser. No. 12/780,876, entitled “DATA LOGGING PERSONAL VAPORIZING INHALER”, now U.S. Pat. No. 9,095,175; and U.S. application Ser. No. 12/780,877, entitled “CHARGING CASE FOR A PERSONAL VAPORIZING INHALER,” now U.S. Pat. No. 8,314,591; wherein the entirety of each of the aforementioned applications is hereby incorporated by reference. This application claims priority as a continuation-in-part to U.S. application Ser. No. 14/285,605, entitled “ASSEMBLY DIRECTED AIRFLOW”, filed on May 22, 2014, which is a continuation-in-part application of U.S. application Ser. No. 12/780,873, entitled “PERSONAL VAPORIZING INHALER CARTRIDGE,” filed May 15, 2010, now U.S. Pat. No. 9,861,772; wherein the entirety of each of the aforementioned applications is hereby incorporated by reference. This application claims priority as a continuation-in-part to U.S. patent application Ser. No. 14/716,204, entitled “CARTRIDGE VAPORIZER IN A PERSONAL VAPORIZER UNIT,” filed on May 19, 2015, which claims priority to U.S. Provisional Application No. 62/000,101, entitled “CARTRIDGE VAPORIZER SYSTEMS, METHODS, AND APPARATUS,” filed on May 19, 2014; wherein the entirety of each of the aforementioned applications is hereby incorporated by reference. This application claims priority as a continuation-in-part to U.S. application Ser. No. 14/275,494, entitled “PERSONAL VAPORIZING INHALER WITH TRANSLUCENT WINDOW”, filed on May 12, 2014, which is a continuation application of U.S. application Ser. No. 12/780,875, entitled “PERSONAL VAPORIZING INHALER WITH INTERNAL LIGHT SOURCE,” filed May 15, 2010, now U.S. Pat. No. 8,757,147; wherein the entirety of each of the aforementioned applications is hereby incorporated by reference. The application is related to U.S. patent application Ser. No. 14/276,894, entitled “VAPORIZER CONFIGURATION, CONTROL, AND REPORTING” filed on May 13, 2014, which is a continuation-in-part to U.S. patent application Ser. No. 12/780,876, entitled “DATA LOGGING PERSONAL VAPORIZING INHALER” filed on May 15, 2010, wherein the entire disclosure of each is herein incorporated by reference. This application is also related to the following U.S. applications: U.S. application Ser. No. 14/273,612, entitled “DISTAL END INSERTED PERSONAL VAPORIZING INHALER CARTRIDGE,” filed on May 9, 2014, now U.S. Pat. No. 9,427,711; U.S. application Ser. No. 14/275,454, entitled “PERSONAL VAPORIZING INHALER ASSEMBLY,” filed on May 12, 2014, now U.S. Pat. No. 9,555,203; U.S. application Ser. No. 14/274,447, entitled “PERSONAL VAPORIZING INHALER WITH DATA TRANSFER,” filed on May 9, 2014; U.S. application Ser. No. 14/278,087, entitled “COMMUNICATION BETWEEN PERSONAL VAPORIZING INHALER ASSEMBLIES,” filed on May 15, 2014, now U.S. Pat. No. 9,861,773; and U.S. application Ser. No. 14/284,994, entitled “VAPORIZER ASSEMBLY AND CARTRIDGE,” filed on May 22, 2014, now U.S. Pat. No. 9,352,288; wherein the entirety of each of the aforementioned applications is hereby incorporated by reference.
Number | Name | Date | Kind |
---|---|---|---|
438310 | Edison | Oct 1890 | A |
705919 | Gill | Jul 1902 | A |
780087 | Burt | Jan 1905 | A |
1016844 | Moonelis | Feb 1912 | A |
1084304 | Vaughn | Jan 1914 | A |
1147416 | MacDonald | Jul 1915 | A |
1347631 | Jean | Jul 1920 | A |
1446087 | Griffin | Feb 1923 | A |
1514682 | Wilson | Nov 1924 | A |
1517584 | Reece | Dec 1924 | A |
1771366 | Wyss et al. | Jul 1930 | A |
1879128 | Despe | Sep 1932 | A |
2032695 | Gimera | Mar 1936 | A |
2057353 | Whittemore, Jr. | Oct 1936 | A |
2086192 | Schumaker | Jul 1937 | A |
2104266 | McCormick | Jan 1938 | A |
2140516 | Cowan | Dec 1938 | A |
2461664 | Smith | Feb 1949 | A |
2472282 | Burchett | Jun 1949 | A |
2545851 | Kardos | Mar 1951 | A |
2959664 | Fenn | Nov 1960 | A |
3060429 | Winston | Oct 1962 | A |
3200819 | Gilbert | Aug 1965 | A |
3203025 | Schreur | Aug 1965 | A |
3234357 | Seuthe | Feb 1966 | A |
3258015 | Ellis et al. | Jun 1966 | A |
3281637 | Hultquist | Oct 1966 | A |
3292635 | Kolodny | Dec 1966 | A |
3356094 | Ellis et al. | Dec 1967 | A |
3385303 | Hind | May 1968 | A |
3428053 | Schoenbaum | Feb 1969 | A |
3431393 | Katsuda | Mar 1969 | A |
3479561 | Janning | Nov 1969 | A |
3486508 | Sipos | Dec 1969 | A |
3502588 | Winberg | Mar 1970 | A |
3516417 | Moses | Jun 1970 | A |
3614056 | Alvarez | Oct 1971 | A |
3651240 | Kirkpatrick | Mar 1972 | A |
3685521 | Dock | Aug 1972 | A |
3685522 | Kleinhans | Aug 1972 | A |
3738374 | Bennett | Jun 1973 | A |
3747120 | Stemme | Jul 1973 | A |
3751969 | Schrock | Aug 1973 | A |
3766000 | Gibson et al. | Oct 1973 | A |
3844294 | Webster | Oct 1974 | A |
3860012 | Selke | Jan 1975 | A |
3878850 | Gibson et al. | Apr 1975 | A |
3931824 | Miano et al. | Jan 1976 | A |
3933643 | Colvin et al. | Jan 1976 | A |
3934117 | Schladitz | Jan 1976 | A |
3943941 | Boyd et al. | Mar 1976 | A |
4016878 | Castel et al. | Apr 1977 | A |
4044777 | Boyd et al. | Aug 1977 | A |
4079742 | Rainer et al. | Mar 1978 | A |
4190046 | Virag | Feb 1980 | A |
4207457 | Haglund et al. | Jun 1980 | A |
4219031 | Rainer et al. | Aug 1980 | A |
4219032 | Tabatznik et al. | Aug 1980 | A |
4233993 | Miano et al. | Nov 1980 | A |
4259970 | Green, Jr. | Apr 1981 | A |
4270552 | Jenkins et al. | Jun 1981 | A |
4284089 | Ray | Aug 1981 | A |
4286604 | Ehretsmann et al. | Sep 1981 | A |
4303083 | Burruss, Jr. | Dec 1981 | A |
4326544 | Hardwick et al. | Apr 1982 | A |
4340072 | Bolt et al. | Jul 1982 | A |
4347855 | Lanzillotti et al. | Sep 1982 | A |
4391285 | Burnett et al. | Jul 1983 | A |
4429703 | Haber | Feb 1984 | A |
4506682 | Muller | Mar 1985 | A |
4531178 | Uke | Jul 1985 | A |
4589428 | Keritsis | May 1986 | A |
4629665 | Matsuo | Dec 1986 | A |
4635651 | Jacobs | Jan 1987 | A |
4637407 | Bonanno et al. | Jan 1987 | A |
4676237 | Wood et al. | Jun 1987 | A |
4700727 | Torigian | Oct 1987 | A |
4708151 | Shelar | Nov 1987 | A |
4714082 | Banerjee et al. | Dec 1987 | A |
4735217 | Gerth et al. | Apr 1988 | A |
4756318 | Clearman et al. | Jul 1988 | A |
4768676 | Kaneko | Sep 1988 | A |
4771295 | Baker et al. | Sep 1988 | A |
4771795 | White et al. | Sep 1988 | A |
4771796 | Myer | Sep 1988 | A |
4776353 | Lilja et al. | Oct 1988 | A |
4793365 | Sensabaugh, Jr. et al. | Dec 1988 | A |
4797692 | Ims | Jan 1989 | A |
4800903 | Ray et al. | Jan 1989 | A |
4807809 | Pryor et al. | Feb 1989 | A |
4819665 | Roberts et al. | Apr 1989 | A |
4823817 | Luke | Apr 1989 | A |
4836225 | Sudoh | Jun 1989 | A |
4848374 | Chard et al. | Jul 1989 | A |
4848376 | Lilja et al. | Jul 1989 | A |
4874000 | Tamol et al. | Oct 1989 | A |
4878506 | Pinck et al. | Nov 1989 | A |
4892109 | Strubel | Jan 1990 | A |
4893639 | White | Jan 1990 | A |
4907606 | Lilja et al. | Mar 1990 | A |
4913168 | Potter et al. | Apr 1990 | A |
4917119 | Potter et al. | Apr 1990 | A |
4917121 | Riehl | Apr 1990 | A |
4917128 | Clearman et al. | Apr 1990 | A |
4920990 | Lawrence et al. | May 1990 | A |
4922901 | Brooks et al. | May 1990 | A |
4924886 | Litzinger | May 1990 | A |
4938236 | Banerjee et al. | Jul 1990 | A |
4941483 | Ridings et al. | Jul 1990 | A |
4941486 | Dube et al. | Jul 1990 | A |
4945448 | Bremenour | Jul 1990 | A |
4945929 | Egilmex | Aug 1990 | A |
4945931 | Gori | Aug 1990 | A |
4947874 | Brooks et al. | Aug 1990 | A |
4947875 | Brooks et al. | Aug 1990 | A |
4961438 | Korte | Oct 1990 | A |
4966171 | Serrano et al. | Oct 1990 | A |
4968263 | Silbernagel | Nov 1990 | A |
4969476 | Bale et al. | Nov 1990 | A |
4972855 | Kuriyama et al. | Nov 1990 | A |
4977908 | Luke | Dec 1990 | A |
4981522 | Nichols et al. | Jan 1991 | A |
4986286 | Roberts et al. | Jan 1991 | A |
4990939 | Sekiya et al. | Feb 1991 | A |
4991606 | Serrano et al. | Feb 1991 | A |
5005593 | Fagg | Apr 1991 | A |
5019122 | Clearman et al. | May 1991 | A |
5020548 | Farrier et al. | Jun 1991 | A |
5025814 | Raker | Jun 1991 | A |
5033483 | Clearman et al. | Jul 1991 | A |
5040551 | Schlatter et al. | Aug 1991 | A |
5042510 | Curtiss et al. | Aug 1991 | A |
5046514 | Bolt | Sep 1991 | A |
5050621 | Creighton et al. | Sep 1991 | A |
5060667 | Strubel | Oct 1991 | A |
5060671 | Counts et al. | Oct 1991 | A |
5060676 | Hearn et al. | Oct 1991 | A |
5065776 | Lawson et al. | Nov 1991 | A |
5072744 | Luke et al. | Dec 1991 | A |
5074321 | Gentry et al. | Dec 1991 | A |
5076296 | Nystrom et al. | Dec 1991 | A |
5076297 | Farrier et al. | Dec 1991 | A |
5092353 | Montoya | Mar 1992 | A |
5093894 | Deevi et al. | Mar 1992 | A |
5095921 | Losee et al. | Mar 1992 | A |
5097850 | Braunshteyn et al. | Mar 1992 | A |
5099861 | Clearman et al. | Mar 1992 | A |
5101839 | Jakob et al. | Apr 1992 | A |
5105835 | Drewett et al. | Apr 1992 | A |
5105836 | Gentry et al. | Apr 1992 | A |
5105837 | Barnes et al. | Apr 1992 | A |
5105838 | White et al. | Apr 1992 | A |
5115820 | Hauser | May 1992 | A |
5124200 | Mallonee | Jun 1992 | A |
5129409 | White et al. | Jul 1992 | A |
5144962 | Counts et al. | Sep 1992 | A |
5146934 | Deevi et al. | Sep 1992 | A |
5148821 | Best et al. | Sep 1992 | A |
5159940 | Hayward et al. | Nov 1992 | A |
5159942 | Brinkley et al. | Nov 1992 | A |
5177424 | Connors | Jan 1993 | A |
5178167 | Riggs et al. | Jan 1993 | A |
5179966 | Losee et al. | Jan 1993 | A |
5183062 | Clearman et al. | Feb 1993 | A |
5203335 | Noujaim et al. | Apr 1993 | A |
5211684 | Shannon et al. | May 1993 | A |
5224265 | Dux et al. | Jul 1993 | A |
5224498 | Deevi et al. | Jul 1993 | A |
5228460 | Sprinkel et al. | Jul 1993 | A |
5240014 | Deevi et al. | Aug 1993 | A |
5240016 | Nichols et al. | Aug 1993 | A |
5246018 | Deevi et al. | Sep 1993 | A |
5249586 | Morgan et al. | Oct 1993 | A |
5255674 | Oftedal et al. | Oct 1993 | A |
5261424 | Sprinkel, Jr. | Nov 1993 | A |
5266746 | Nishihara | Nov 1993 | A |
5269327 | Counts et al. | Dec 1993 | A |
5271419 | Arzonico et al. | Dec 1993 | A |
5282798 | Bruse et al. | Feb 1994 | A |
5285798 | Banerjee et al. | Feb 1994 | A |
5293883 | Edwards | Mar 1994 | A |
5322075 | Deevi et al. | Jun 1994 | A |
5327915 | Porenski et al. | Jul 1994 | A |
5327917 | Lekwauwa et al. | Jul 1994 | A |
5345951 | Serrano et al. | Sep 1994 | A |
5345955 | Clearman et al. | Sep 1994 | A |
5353813 | Deevi et al. | Oct 1994 | A |
5357984 | Farrier et al. | Oct 1994 | A |
5360023 | Blakley et al. | Nov 1994 | A |
5366122 | Guentert et al. | Nov 1994 | A |
5369723 | Counts et al. | Nov 1994 | A |
5372148 | McCafferty et al. | Dec 1994 | A |
5388574 | Ingebrethsen | Feb 1995 | A |
5388594 | Counts et al. | Feb 1995 | A |
5396911 | Casey, III et al. | Mar 1995 | A |
5408574 | Deevi et al. | Apr 1995 | A |
5468936 | Deevi et al. | Nov 1995 | A |
5479948 | Counts et al. | Jan 1996 | A |
5497791 | Bowen et al. | Mar 1996 | A |
5498850 | Das | Mar 1996 | A |
5498855 | Deevi et al. | Mar 1996 | A |
5499636 | Baggett, Jr. et al. | Mar 1996 | A |
5505214 | Collins et al. | Apr 1996 | A |
5515842 | Ramseyer et al. | May 1996 | A |
5521576 | Collins | May 1996 | A |
5530225 | Hajaligol | Jun 1996 | A |
5533530 | Young et al. | Jul 1996 | A |
5551451 | Riggs et al. | Sep 1996 | A |
5564442 | MacDonald et al. | Oct 1996 | A |
5573692 | Das et al. | Nov 1996 | A |
5588446 | Clearman | Dec 1996 | A |
5591368 | Fleischhauer et al. | Jan 1997 | A |
5593792 | Farrier et al. | Jan 1997 | A |
5595577 | Bensalem et al. | Jan 1997 | A |
5595706 | Sikka et al. | Jan 1997 | A |
5598868 | Jakob et al. | Feb 1997 | A |
5611360 | Tang | Mar 1997 | A |
5613504 | Collins et al. | Mar 1997 | A |
5613505 | Campbell et al. | Mar 1997 | A |
5637430 | Shimizu et al. | Jun 1997 | A |
5646666 | Cowger et al. | Jul 1997 | A |
5649554 | Sprinkel et al. | Jul 1997 | A |
5659656 | Das | Aug 1997 | A |
5665262 | Hajaligol et al. | Sep 1997 | A |
5666976 | Adams et al. | Sep 1997 | A |
5666977 | Higgins et al. | Sep 1997 | A |
5666978 | Counts et al. | Sep 1997 | A |
5687746 | Rose et al. | Nov 1997 | A |
5692525 | Counts et al. | Dec 1997 | A |
5692526 | Adams et al. | Dec 1997 | A |
5703633 | Gehrer et al. | Dec 1997 | A |
5708258 | Counts et al. | Jan 1998 | A |
5709202 | Lloyd et al. | Jan 1998 | A |
5715844 | Young et al. | Feb 1998 | A |
5726421 | Fleischhauer et al. | Mar 1998 | A |
5727571 | Meiring et al. | Mar 1998 | A |
5730158 | Collins et al. | Mar 1998 | A |
5732685 | Nakamura | Mar 1998 | A |
5743251 | Howell et al. | Apr 1998 | A |
5745985 | Ghosh et al. | May 1998 | A |
5750964 | Counts et al. | May 1998 | A |
5778899 | Saito et al. | Jul 1998 | A |
5799663 | Gross et al. | Sep 1998 | A |
5816263 | Counts et al. | Oct 1998 | A |
5819751 | Barnes et al. | Oct 1998 | A |
5819756 | Mielordt | Oct 1998 | A |
5829453 | White et al. | Nov 1998 | A |
5865185 | Collins et al. | Feb 1999 | A |
5865186 | Volsey, II | Feb 1999 | A |
5878752 | Adams et al. | Mar 1999 | A |
5880439 | Deevi et al. | Mar 1999 | A |
5893371 | Rose et al. | Apr 1999 | A |
5894841 | Voges | Apr 1999 | A |
5915387 | Baggett, Jr. et al. | Jun 1999 | A |
5934289 | Watkins et al. | Aug 1999 | A |
5944025 | Cook et al. | Aug 1999 | A |
5954979 | Counts et al. | Sep 1999 | A |
5967148 | Harris et al. | Oct 1999 | A |
5996589 | St. Charles | Dec 1999 | A |
6026820 | Baggett, Jr. et al. | Feb 2000 | A |
6033623 | Deevi et al. | Mar 2000 | A |
6040560 | Fleischhauer et al. | Mar 2000 | A |
6053176 | Adams et al. | Apr 2000 | A |
6062213 | Fuisz et al. | May 2000 | A |
6089857 | Matsuura et al. | Jul 2000 | A |
6095152 | Beven et al. | Aug 2000 | A |
6095153 | Kessler et al. | Aug 2000 | A |
6102036 | Slutsky et al. | Aug 2000 | A |
6102688 | Mifune et al. | Aug 2000 | A |
6116247 | Banyasz et al. | Sep 2000 | A |
6119700 | Fleischhauer et al. | Sep 2000 | A |
6125853 | Susa et al. | Oct 2000 | A |
6125866 | Nichols et al. | Oct 2000 | A |
6146934 | Gardner et al. | Nov 2000 | A |
6155268 | Takeuchi | Dec 2000 | A |
6164287 | White | Dec 2000 | A |
6182670 | White et al. | Feb 2001 | B1 |
6196218 | Voges | Mar 2001 | B1 |
6196219 | Hess et al. | Mar 2001 | B1 |
6217315 | Mifune et al. | Apr 2001 | B1 |
6232784 | Dulasky | May 2001 | B1 |
6234167 | Cox et al. | May 2001 | B1 |
6285017 | Brickell | Sep 2001 | B1 |
6289898 | Fournier et al. | Sep 2001 | B1 |
6311561 | Bang et al. | Nov 2001 | B1 |
6322268 | Kaufmann et al. | Nov 2001 | B1 |
6349728 | Pham | Feb 2002 | B1 |
6397852 | McAdam | Jun 2002 | B1 |
6408856 | McAdam | Jun 2002 | B1 |
6418938 | Fleischhauer et al. | Jul 2002 | B1 |
6443146 | Voges | Sep 2002 | B1 |
6446426 | Sweeney et al. | Sep 2002 | B1 |
6476151 | Araki et al. | Nov 2002 | B1 |
6501052 | Cox et al. | Dec 2002 | B2 |
6516796 | Cox et al. | Feb 2003 | B1 |
6532965 | Abhulimen et al. | Mar 2003 | B1 |
6537186 | Veluz | Mar 2003 | B1 |
6557552 | Cox et al. | May 2003 | B1 |
6578584 | Beven et al. | Jun 2003 | B1 |
6591841 | White et al. | Jul 2003 | B1 |
6598607 | Adiga et al. | Jul 2003 | B2 |
6601776 | Oljaca et al. | Aug 2003 | B1 |
6615840 | Fournier et al. | Sep 2003 | B1 |
6620659 | Emmma et al. | Sep 2003 | B2 |
6637430 | Voges et al. | Oct 2003 | B1 |
6681769 | Sprinkel, Jr. et al. | Jan 2004 | B2 |
6688313 | Wrenn et al. | Feb 2004 | B2 |
6690121 | Weindorf | Feb 2004 | B1 |
6715494 | McCoy | Apr 2004 | B1 |
6719443 | Gutstein et al. | Apr 2004 | B2 |
6722763 | Hsu et al. | Apr 2004 | B1 |
6730832 | Dominguez et al. | May 2004 | B1 |
6766220 | McRae et al. | Jul 2004 | B2 |
6772756 | Shayan | Aug 2004 | B2 |
6772757 | Sprinkel, Jr. | Aug 2004 | B2 |
6803545 | Blake et al. | Oct 2004 | B2 |
6803550 | Sharpe et al. | Oct 2004 | B2 |
6804458 | Sherwood et al. | Oct 2004 | B2 |
6810883 | Felter et al. | Nov 2004 | B2 |
6823873 | Nichols et al. | Nov 2004 | B2 |
6854461 | Nichols et al. | Feb 2005 | B2 |
6854470 | Pu | Feb 2005 | B1 |
6885814 | Saito et al. | Apr 2005 | B2 |
6923179 | Gupta et al. | Aug 2005 | B2 |
6938986 | Macler et al. | Sep 2005 | B2 |
6994096 | Rostami et al. | Feb 2006 | B2 |
7040314 | Nguyen et al. | May 2006 | B2 |
7117867 | Cox et al. | Oct 2006 | B2 |
7147170 | Nguyen et al. | Dec 2006 | B2 |
7163015 | Moffitt | Jan 2007 | B2 |
7167776 | Maharajh et al. | Jan 2007 | B2 |
7173222 | Cox et al. | Feb 2007 | B2 |
7185659 | Sharpe | Mar 2007 | B2 |
7234470 | Yang | Jun 2007 | B2 |
7284424 | Kanke et al. | Oct 2007 | B2 |
7290549 | Banerjee et al. | Nov 2007 | B2 |
7293565 | Griffin et al. | Nov 2007 | B2 |
7337782 | Thompson | Mar 2008 | B2 |
7392809 | Larson et al. | Jul 2008 | B2 |
7400940 | McRae et al. | Jul 2008 | B2 |
7445007 | Balch et al. | Nov 2008 | B2 |
7500479 | Nichols et al. | Mar 2009 | B2 |
7513253 | Kobayashi et al. | Apr 2009 | B2 |
7645442 | Hale et al. | Jan 2010 | B2 |
7690385 | Moffitt | Apr 2010 | B2 |
7692123 | Baba et al. | Apr 2010 | B2 |
7726320 | Robinson et al. | Jun 2010 | B2 |
7775459 | Martens, III et al. | Aug 2010 | B2 |
7810505 | Yang | Oct 2010 | B2 |
7832410 | Hon | Nov 2010 | B2 |
7845359 | Montaser | Dec 2010 | B2 |
7896006 | Hamano et al. | Mar 2011 | B2 |
7983113 | Krueger et al. | Jul 2011 | B2 |
7997280 | Rosenthal | Aug 2011 | B2 |
8003080 | Rabinowitz et al. | Aug 2011 | B2 |
8042550 | Urtsev et al. | Oct 2011 | B2 |
8079371 | Robinson et al. | Dec 2011 | B2 |
8091558 | Martzel | Jan 2012 | B2 |
8127772 | Montaser | Mar 2012 | B2 |
8156944 | Han | Apr 2012 | B2 |
8191555 | Herbrich et al. | Jun 2012 | B2 |
8205622 | Pan | Jun 2012 | B2 |
8291918 | Magnon | Oct 2012 | B2 |
8314591 | Terry et al. | Nov 2012 | B2 |
8322350 | Lipowicz | Dec 2012 | B2 |
8342184 | Inagaki et al. | Jan 2013 | B2 |
8365742 | Hon | Feb 2013 | B2 |
8371310 | Brenneise | Feb 2013 | B2 |
8375957 | Hon | Feb 2013 | B2 |
8393331 | Hon | Mar 2013 | B2 |
8402976 | Fernando et al. | Mar 2013 | B2 |
8430106 | Potter et al. | Apr 2013 | B2 |
8434478 | Yamada et al. | May 2013 | B2 |
8459271 | Inagaki | Jun 2013 | B2 |
8479747 | O'Connell | Jul 2013 | B2 |
8490628 | Hon | Jul 2013 | B2 |
8495998 | Schennum | Jul 2013 | B2 |
8499766 | Newton | Aug 2013 | B1 |
8505548 | Hearn | Aug 2013 | B2 |
8511318 | Hon | Aug 2013 | B2 |
8517032 | Urtsev et al. | Aug 2013 | B2 |
8528569 | Newton | Sep 2013 | B1 |
8539959 | Scatterday | Sep 2013 | B1 |
8550068 | Terry et al. | Oct 2013 | B2 |
8550069 | Alelov | Oct 2013 | B2 |
8558147 | Greim et al. | Oct 2013 | B2 |
8578942 | Schennum | Nov 2013 | B2 |
8596460 | Scatterday | Dec 2013 | B2 |
8602037 | Inagaki | Dec 2013 | B2 |
8634709 | Maharajh et al. | Jan 2014 | B2 |
8678012 | Li et al. | Mar 2014 | B2 |
8689786 | Schennum | Apr 2014 | B2 |
8689804 | Fernando et al. | Apr 2014 | B2 |
8689805 | Hon | Apr 2014 | B2 |
8695794 | Scatterday | Apr 2014 | B2 |
8707965 | Newton | Apr 2014 | B2 |
8714161 | Liu | May 2014 | B2 |
8733345 | Siller | May 2014 | B2 |
8733346 | Rinker | May 2014 | B2 |
8746240 | Terry et al. | Jun 2014 | B2 |
8752557 | Lipowicz | Jun 2014 | B2 |
8757169 | Gysland | Jun 2014 | B2 |
8893726 | Hon | Nov 2014 | B2 |
8899228 | Linton et al. | Dec 2014 | B2 |
10036548 | Liu | Jul 2018 | B2 |
20010026788 | Piskorz | Oct 2001 | A1 |
20020136886 | He et al. | Sep 2002 | A1 |
20020146242 | Vieira | Oct 2002 | A1 |
20030011579 | Gong et al. | Jan 2003 | A1 |
20030033055 | McRae et al. | Feb 2003 | A1 |
20030108342 | Sherwood et al. | Jun 2003 | A1 |
20030131859 | Li et al. | Jul 2003 | A1 |
20030189826 | Yoon | Oct 2003 | A1 |
20030226837 | Blake et al. | Dec 2003 | A1 |
20040020500 | Wrenn et al. | Feb 2004 | A1 |
20040020508 | Earl | Feb 2004 | A1 |
20040035409 | Harwig et al. | Feb 2004 | A1 |
20040055613 | Horian | Mar 2004 | A1 |
20040084044 | Childers et al. | May 2004 | A1 |
20040089314 | Felter et al. | May 2004 | A1 |
20040118401 | Smith et al. | Jun 2004 | A1 |
20040129280 | Woodson et al. | Jul 2004 | A1 |
20040149282 | Hickle | Aug 2004 | A1 |
20040149296 | Rostami et al. | Aug 2004 | A1 |
20040173229 | Crooks et al. | Sep 2004 | A1 |
20040198127 | Yamamoto et al. | Oct 2004 | A1 |
20040200488 | Felter et al. | Oct 2004 | A1 |
20040226568 | Takeuchi et al. | Nov 2004 | A1 |
20040234916 | Hale et al. | Nov 2004 | A1 |
20040261802 | Griffin et al. | Dec 2004 | A1 |
20050016549 | Banerjee et al. | Jan 2005 | A1 |
20050016550 | Katase | Jan 2005 | A1 |
20050066986 | Nestor et al. | Mar 2005 | A1 |
20050115243 | Adle | Jun 2005 | A1 |
20050172976 | Newman et al. | Aug 2005 | A1 |
20060016453 | Kim | Jan 2006 | A1 |
20060021614 | Wermeling et al. | Feb 2006 | A1 |
20060070633 | Rostami et al. | Apr 2006 | A1 |
20060093977 | Pellizzari et al. | May 2006 | A1 |
20060185687 | Hearn et al. | Aug 2006 | A1 |
20060196518 | Hon | Sep 2006 | A1 |
20060221594 | Thuot Rann et al. | Oct 2006 | A1 |
20060283468 | Lipowicz | Dec 2006 | A1 |
20070030306 | Okamura et al. | Feb 2007 | A1 |
20070062549 | Holton et al. | Mar 2007 | A1 |
20070074734 | Braunshteyn et al. | Apr 2007 | A1 |
20070102013 | Adams et al. | May 2007 | A1 |
20070215167 | Llewellyn Crooks et al. | Sep 2007 | A1 |
20070240711 | Hamano | Oct 2007 | A1 |
20070267031 | Hon | Nov 2007 | A1 |
20070283972 | Monsees et al. | Dec 2007 | A1 |
20080056691 | Wingo et al. | Mar 2008 | A1 |
20080085103 | Beland et al. | Apr 2008 | A1 |
20080092912 | Robinson et al. | Apr 2008 | A1 |
20080099011 | Gonda et al. | May 2008 | A1 |
20080138423 | Gonda | Jun 2008 | A1 |
20080149118 | Oglesby et al. | Jun 2008 | A1 |
20080257367 | Paterno et al. | Oct 2008 | A1 |
20080276947 | Martzel | Nov 2008 | A1 |
20080302374 | Wengert et al. | Dec 2008 | A1 |
20090065010 | Shands | Mar 2009 | A1 |
20090095311 | Han | Apr 2009 | A1 |
20090095312 | Herbrich et al. | Apr 2009 | A1 |
20090114737 | Yu et al. | May 2009 | A1 |
20090126745 | Hon | May 2009 | A1 |
20090151717 | Bowen et al. | Jun 2009 | A1 |
20090178672 | Mullinger et al. | Jul 2009 | A1 |
20090188490 | Han | Jul 2009 | A1 |
20090230117 | Fernando et al. | Sep 2009 | A1 |
20090255534 | Paterno | Oct 2009 | A1 |
20090260641 | Monsees et al. | Oct 2009 | A1 |
20090260642 | Monsees et al. | Oct 2009 | A1 |
20090272379 | Thorens et al. | Nov 2009 | A1 |
20090283103 | Nielsen et al. | Nov 2009 | A1 |
20090293892 | Williams et al. | Dec 2009 | A1 |
20090320864 | Rowley | Dec 2009 | A1 |
20100024834 | Oglesby et al. | Feb 2010 | A1 |
20100031968 | Sheikh et al. | Feb 2010 | A1 |
20100043809 | Magnon | Feb 2010 | A1 |
20100059073 | Hoffmann et al. | Mar 2010 | A1 |
20100083959 | Siller | Apr 2010 | A1 |
20100126505 | Rinker | May 2010 | A1 |
20100163063 | Fernando et al. | Jul 2010 | A1 |
20100200006 | Robinson et al. | Aug 2010 | A1 |
20100229881 | Hearn | Sep 2010 | A1 |
20100242974 | Pan | Sep 2010 | A1 |
20100242975 | Hearn | Sep 2010 | A1 |
20100242976 | Katayama et al. | Sep 2010 | A1 |
20100300467 | Kuistila et al. | Dec 2010 | A1 |
20100307518 | Wang | Dec 2010 | A1 |
20100313901 | Fernando et al. | Dec 2010 | A1 |
20110005535 | Xiu | Jan 2011 | A1 |
20110011286 | Strasser | Jan 2011 | A1 |
20110011396 | Fang | Jan 2011 | A1 |
20110036363 | Urtsev et al. | Feb 2011 | A1 |
20110036365 | Chong et al. | Feb 2011 | A1 |
20110094523 | Thorens et al. | Apr 2011 | A1 |
20110120482 | Brenneise | May 2011 | A1 |
20110126848 | Zuber et al. | Jun 2011 | A1 |
20110147486 | Greim et al. | Jun 2011 | A1 |
20110155153 | Thorens et al. | Jun 2011 | A1 |
20110155718 | Greim et al. | Jun 2011 | A1 |
20110162663 | Bryman | Jul 2011 | A1 |
20110168194 | Hon | Jul 2011 | A1 |
20110226236 | Buchberger | Sep 2011 | A1 |
20110232654 | Mass | Sep 2011 | A1 |
20110265806 | Alarcon et al. | Nov 2011 | A1 |
20110266236 | Clark et al. | Nov 2011 | A1 |
20110277760 | Terry et al. | Nov 2011 | A1 |
20110277761 | Terry et al. | Nov 2011 | A1 |
20110277764 | Terry et al. | Nov 2011 | A1 |
20110277780 | Terry et al. | Nov 2011 | A1 |
20110290244 | Schennum | Dec 2011 | A1 |
20110290248 | Schennum | Dec 2011 | A1 |
20110290266 | Koller | Dec 2011 | A1 |
20110290267 | Yamada et al. | Dec 2011 | A1 |
20110290269 | Shimizu | Dec 2011 | A1 |
20110297166 | Takeuchi et al. | Dec 2011 | A1 |
20110304282 | Li et al. | Dec 2011 | A1 |
20110309157 | Yang et al. | Dec 2011 | A1 |
20120006342 | Rose et al. | Jan 2012 | A1 |
20120006343 | Renaud et al. | Jan 2012 | A1 |
20120042885 | Stone et al. | Feb 2012 | A1 |
20120060853 | Robinson et al. | Mar 2012 | A1 |
20120111346 | Rinker et al. | May 2012 | A1 |
20120111347 | Hon | May 2012 | A1 |
20120118301 | Montaser | May 2012 | A1 |
20120118307 | Tu | May 2012 | A1 |
20120132643 | Choi et al. | May 2012 | A1 |
20120138052 | Hearn et al. | Jun 2012 | A1 |
20120138054 | Hearn et al. | Jun 2012 | A1 |
20120145169 | Wu | Jun 2012 | A1 |
20120152244 | Yomtov | Jun 2012 | A1 |
20120152246 | Yomtov | Jun 2012 | A1 |
20120160251 | Hammel et al. | Jun 2012 | A1 |
20120167906 | Gysland | Jul 2012 | A1 |
20120186594 | Liu | Jul 2012 | A1 |
20120199146 | Marangos | Aug 2012 | A1 |
20120199663 | Qiu | Aug 2012 | A1 |
20120204889 | Xiu | Aug 2012 | A1 |
20120211015 | Li et al. | Aug 2012 | A1 |
20120227752 | Alelov | Sep 2012 | A1 |
20120231464 | Yu et al. | Sep 2012 | A1 |
20120234315 | Li et al. | Sep 2012 | A1 |
20120247494 | Oglesby et al. | Oct 2012 | A1 |
20120255567 | Rose et al. | Oct 2012 | A1 |
20120260926 | Tu et al. | Oct 2012 | A1 |
20120260927 | Liu | Oct 2012 | A1 |
20120273589 | Hon | Nov 2012 | A1 |
20120279512 | Hon | Nov 2012 | A1 |
20120285475 | Liu | Nov 2012 | A1 |
20120298123 | Woodcock et al. | Nov 2012 | A1 |
20120312313 | Frija | Dec 2012 | A1 |
20120318882 | Abehasera | Dec 2012 | A1 |
20120325227 | Robinson et al. | Dec 2012 | A1 |
20120325228 | Williams | Dec 2012 | A1 |
20130008457 | Zheng et al. | Jan 2013 | A1 |
20130019862 | Yamada et al. | Jan 2013 | A1 |
20130019887 | Liu | Jan 2013 | A1 |
20130025609 | Liu | Jan 2013 | A1 |
20130037031 | Gredat | Feb 2013 | A1 |
20130037041 | Worm et al. | Feb 2013 | A1 |
20130037042 | Hearn et al. | Feb 2013 | A1 |
20130042865 | Monsees et al. | Feb 2013 | A1 |
20130056012 | Hearn et al. | Mar 2013 | A1 |
20130056013 | Terry et al. | Mar 2013 | A1 |
20130061861 | Hearn | Mar 2013 | A1 |
20130068239 | Youn | Mar 2013 | A1 |
20130074854 | Lipowicz | Mar 2013 | A1 |
20130074857 | Buchberger | Mar 2013 | A1 |
20130081623 | Buchberger | Apr 2013 | A1 |
20130081625 | Rustad et al. | Apr 2013 | A1 |
20130081642 | Safari | Apr 2013 | A1 |
20130087160 | Gherghe | Apr 2013 | A1 |
20130104916 | Bellinger et al. | May 2013 | A1 |
20130125906 | Hon | May 2013 | A1 |
20130139833 | Hon | Jun 2013 | A1 |
20130140200 | Scatterday | Jun 2013 | A1 |
20130146489 | Scatterday | Jun 2013 | A1 |
20130152954 | Youn | Jun 2013 | A1 |
20130160764 | Liu | Jun 2013 | A1 |
20130160765 | Liu | Jun 2013 | A1 |
20130167853 | Liu | Jul 2013 | A1 |
20130167854 | Shin | Jul 2013 | A1 |
20130169230 | Li et al. | Jul 2013 | A1 |
20130180533 | Kim et al. | Jul 2013 | A1 |
20130192615 | Tucker et al. | Aug 2013 | A1 |
20130192616 | Tucker et al. | Aug 2013 | A1 |
20130192617 | Thompson | Aug 2013 | A1 |
20130192618 | Li et al. | Aug 2013 | A1 |
20130192619 | Tucker et al. | Aug 2013 | A1 |
20130192620 | Tucker et al. | Aug 2013 | A1 |
20130192621 | Li et al. | Aug 2013 | A1 |
20130192622 | Tucker et al. | Aug 2013 | A1 |
20130192623 | Tucker et al. | Aug 2013 | A1 |
20130199528 | Goodman et al. | Aug 2013 | A1 |
20130206154 | Fernando et al. | Aug 2013 | A1 |
20130213417 | Chong et al. | Aug 2013 | A1 |
20130213418 | Tucker et al. | Aug 2013 | A1 |
20130213419 | Tucker et al. | Aug 2013 | A1 |
20130213420 | Hon | Aug 2013 | A1 |
20130220315 | Conley et al. | Aug 2013 | A1 |
20130220316 | Oglesby et al. | Aug 2013 | A1 |
20130228190 | Weiss et al. | Sep 2013 | A1 |
20130243410 | Nichols et al. | Sep 2013 | A1 |
20130247924 | Scatterday et al. | Sep 2013 | A1 |
20130248385 | Scatterday et al. | Sep 2013 | A1 |
20130255675 | Liu | Oct 2013 | A1 |
20130255702 | Griffith, Jr. et al. | Oct 2013 | A1 |
20130263869 | Zhu | Oct 2013 | A1 |
20130276798 | Hon | Oct 2013 | A1 |
20130276799 | Davidson et al. | Oct 2013 | A1 |
20130276802 | Scatterday | Oct 2013 | A1 |
20130276804 | Hon | Oct 2013 | A1 |
20130284190 | Scatterday et al. | Oct 2013 | A1 |
20130284191 | Scatterday et al. | Oct 2013 | A1 |
20130284192 | Peleg et al. | Oct 2013 | A1 |
20130284194 | Newton | Oct 2013 | A1 |
20130298905 | Levin et al. | Nov 2013 | A1 |
20130298922 | Xiang et al. | Nov 2013 | A1 |
20130300350 | Xiang | Nov 2013 | A1 |
20130306064 | Thorens et al. | Nov 2013 | A1 |
20130306065 | Thorens et al. | Nov 2013 | A1 |
20130306074 | Bowditch et al. | Nov 2013 | A1 |
20130306084 | Flick | Nov 2013 | A1 |
20130306692 | Mangum et al. | Nov 2013 | A1 |
20130312739 | Rome et al. | Nov 2013 | A1 |
20130312742 | Monsees et al. | Nov 2013 | A1 |
20130313139 | Scatterday et al. | Nov 2013 | A1 |
20130319404 | Feriani et al. | Dec 2013 | A1 |
20130319407 | Liu | Dec 2013 | A1 |
20130319431 | Cyphert et al. | Dec 2013 | A1 |
20130319435 | Flick | Dec 2013 | A1 |
20130319436 | Liu | Dec 2013 | A1 |
20130319438 | Liu | Dec 2013 | A1 |
20130319439 | Gorelick et al. | Dec 2013 | A1 |
20130319440 | Capuano | Dec 2013 | A1 |
20130319989 | Liu | Dec 2013 | A1 |
20130319999 | Plojoux et al. | Dec 2013 | A1 |
20130333700 | Buchberger | Dec 2013 | A1 |
20130333711 | Liu | Dec 2013 | A1 |
20130333712 | Scatterday | Dec 2013 | A1 |
20130336358 | Liu | Dec 2013 | A1 |
20130340750 | Thorens et al. | Dec 2013 | A1 |
20130340775 | Juster et al. | Dec 2013 | A1 |
20130340778 | Liu | Dec 2013 | A1 |
20130340779 | Liu | Dec 2013 | A1 |
20130341218 | Liu | Dec 2013 | A1 |
20130342157 | Liu | Dec 2013 | A1 |
20140000636 | O'Connell | Jan 2014 | A1 |
20140000637 | O'Connell | Jan 2014 | A1 |
20140000638 | Sebastian et al. | Jan 2014 | A1 |
20140004844 | Ge | Jan 2014 | A1 |
20140007891 | Liu | Jan 2014 | A1 |
20140007892 | Liu | Jan 2014 | A1 |
20140014124 | Glasberg et al. | Jan 2014 | A1 |
20140014125 | Fernando et al. | Jan 2014 | A1 |
20140014126 | Peleg et al. | Jan 2014 | A1 |
20140020693 | Cochand et al. | Jan 2014 | A1 |
20140020696 | Liu | Jan 2014 | A1 |
20140020697 | Liu | Jan 2014 | A1 |
20140034070 | Schennum | Feb 2014 | A1 |
20140034071 | Levitz et al. | Feb 2014 | A1 |
20140041655 | Barron et al. | Feb 2014 | A1 |
20140044857 | Hua et al. | Feb 2014 | A1 |
20140048086 | Zhanghua | Feb 2014 | A1 |
20140053856 | Liu | Feb 2014 | A1 |
20140053857 | Liu | Feb 2014 | A1 |
20140053858 | Liu | Feb 2014 | A1 |
20140060524 | Liu | Mar 2014 | A1 |
20140060527 | Liu | Mar 2014 | A1 |
20140060528 | Liu | Mar 2014 | A1 |
20140060529 | Zhang | Mar 2014 | A1 |
20140060554 | Collett et al. | Mar 2014 | A1 |
20140060555 | Chang et al. | Mar 2014 | A1 |
20140060556 | Liu | Mar 2014 | A1 |
20140062417 | Li et al. | Mar 2014 | A1 |
20140069424 | Poston et al. | Mar 2014 | A1 |
20140069425 | Zhang | Mar 2014 | A1 |
20140069444 | Cyphert et al. | Mar 2014 | A1 |
20140076310 | Newton | Mar 2014 | A1 |
20140083442 | Scatterday | Mar 2014 | A1 |
20140083443 | Liu | Mar 2014 | A1 |
20140096781 | Sears et al. | Apr 2014 | A1 |
20140096782 | Ampolini et al. | Apr 2014 | A1 |
20140102463 | Jones | Apr 2014 | A1 |
20140103020 | Al-Qaffas | Apr 2014 | A1 |
20140107815 | LaMothe | Apr 2014 | A1 |
20140109898 | Li et al. | Apr 2014 | A1 |
20140109905 | Yamada et al. | Apr 2014 | A1 |
20140109921 | Chen | Apr 2014 | A1 |
20140116455 | Youn | May 2014 | A1 |
20140123989 | LaMothe | May 2014 | A1 |
20140123990 | Timmermans | May 2014 | A1 |
20140130796 | Liu | May 2014 | A1 |
20140130797 | Liu | May 2014 | A1 |
20140130816 | Liu | May 2014 | A1 |
20140130817 | Li et al. | May 2014 | A1 |
20140144453 | Capuano et al. | May 2014 | A1 |
20140150783 | Liu | Jun 2014 | A1 |
20140150784 | Liu | Jun 2014 | A1 |
20140150785 | Malik et al. | Jun 2014 | A1 |
20140150810 | Hon | Jun 2014 | A1 |
20140157583 | Ward et al. | Jun 2014 | A1 |
20140166027 | Fuisz et al. | Jun 2014 | A1 |
20140166028 | Fuisz et al. | Jun 2014 | A1 |
20140166029 | Weigensberg et al. | Jun 2014 | A1 |
20140166030 | Li et al. | Jun 2014 | A1 |
20140174459 | Burstyn | Jun 2014 | A1 |
20140174968 | Scatterday | Jun 2014 | A1 |
20140182608 | Egoyants et al. | Jul 2014 | A1 |
20140182610 | Liu | Jul 2014 | A1 |
20140182611 | Liu | Jul 2014 | A1 |
20140182612 | Chen | Jul 2014 | A1 |
20140186015 | Breiwa, III et al. | Jul 2014 | A1 |
20140196736 | Fernando et al. | Jul 2014 | A1 |
20140209105 | Sears et al. | Jul 2014 | A1 |
20140253144 | Novak, III et al. | Sep 2014 | A1 |
20140261408 | DePiano et al. | Sep 2014 | A1 |
20140261486 | Potter et al. | Sep 2014 | A1 |
20140261487 | Chapman et al. | Sep 2014 | A1 |
20140261495 | Novak, III et al. | Sep 2014 | A1 |
20140270727 | Ampolini et al. | Sep 2014 | A1 |
20140270729 | DePiano et al. | Sep 2014 | A1 |
20140270730 | DePiano et al. | Sep 2014 | A1 |
20140299125 | Buchberger | Oct 2014 | A1 |
20140305453 | Hon | Oct 2014 | A1 |
20140318560 | Hon | Oct 2014 | A1 |
20140345631 | Bowen et al. | Nov 2014 | A1 |
Number | Date | Country |
---|---|---|
276250 | Jul 1965 | AU |
2293957 | Oct 1998 | CN |
1233436 | Nov 1999 | CN |
1541577 | Nov 2004 | CN |
2719043 | Aug 2005 | CN |
201018927 | Feb 2008 | CN |
201067079 | Jun 2008 | CN |
201085044 | Jul 2008 | CN |
2704218 | Aug 1978 | DE |
102006004484 | Aug 2007 | DE |
0295122 | Dec 1988 | EP |
0358114 | Mar 1990 | EP |
0430559 | Jun 1991 | EP |
0430566 | Jun 1991 | EP |
0501419 | Sep 1992 | EP |
0503767 | Sep 1992 | EP |
0845220 | Jun 1998 | EP |
1584910 | Oct 2005 | EP |
1618803 | Jan 2006 | EP |
191125575 | Mar 1912 | GB |
588117 | May 1947 | GB |
755475 | Aug 1956 | GB |
1431045 | Apr 1976 | GB |
2070409 | Sep 1981 | GB |
H9-326299 | Dec 1997 | JP |
2000041654 | Feb 2000 | JP |
P2001-291598 | Oct 2001 | JP |
2002-0067473 | Aug 2002 | KR |
WO-1986002528 | May 1986 | WO |
WO-1997048293 | Dec 1997 | WO |
WO-1998016125 | Apr 1998 | WO |
WO-2000028843 | May 2000 | WO |
WO-2002037990 | May 2002 | WO |
WO-2004080216 | Sep 2004 | WO |
WO-2004095955 | Nov 2004 | WO |
WO-2005099494 | Oct 2005 | WO |
WO-2007078273 | Jul 2007 | WO |
WO-2007131449 | Nov 2007 | WO |
WO-2007131450 | Nov 2007 | WO |
WO-2008139411 | Nov 2008 | WO |
Entry |
---|
U.S. Appl. No. 16/199,438, filed Nov. 26, 2018, Noah Mark Minskoff et al. |
U.S. Appl. No. 17/658,210, filed Apr. 6, 2022, Nathan Andrew Terry et al. |
U.S. Appl. No. 17/900,123, filed Aug. 31, 2022, Nathan Andrew Terry et al. |
U.S. Appl. No. 17/943,889, filed Sep. 13, 2022, Nathan Andrew Terry et al. |
Andrus et al., “Nicotine Microaerosol Inhaler”, Can Respir Journal, vol. 6, No. 6, 1999, pp. 509-512. |
Avallone et al., “Mark's Standard Handbook for Mechanical Engineers,” published 1978, p. 15-6 (3 pg.). |
Cengel et al., “Thermodynamics: An Engineering Approach,” (5th ed. 2006) (excerpts) (“Thermodynamics”), 9 pgs. |
Dally, James W., “Packaging of Electronic Systems: A Mechanical Engineering Approach” (excerpts) (1990), 18 pgs. |
Fuchs, N.A. “The Mechanics of Aerosols” (1989), 22 pgs. |
Messler, Jr., Robert W., “Joining of Materials and Structures,” Elsevier Butterworth-Heinemann 2004—Excerpt, 4 pgs. |
Mosdesign Semiconductor Corp. Datasheet for M1600 LED Drivers (“Mosdesign M1600 Datasheet”), 1 pg. |
MPL 502 Series Specifications, Micro Pneumatic Logic, Inc., (Mar. 11, 2006), http://www.pressureswitch.com/PDFs/0502STANDARDA.pdf [https ://web.archive .org/web/20060311132848/ http://vwww.pressureswitch.com/PDFs/0502STANDARDA.pdf], 17 pqs. |
MPL Pressure Switch Solutions, Micro Pneumatic Logic, Inc., (Product Brochure) (Mar. 11, 2006), http://www.pressureswitch.com/PDFs/2000_MPLBrochure.pdf [https://web.archive.org/web/20060311132419/ htto://www.pressuresvvitd1.com/PDFs/2000 MPLBrochure.pdf]. 2 pgs. |
Rohsenow, Warren M., “Heat, Mass, and Momentum Transfer”, copyright 1961 Prentice-Hall, 3 pgs. |
Speck, James A., “Mechanical Fastening, Joining, and Assembly,” Marcel Dekker, Inc. 1997, 4 pgs. |
Thermal Ink-Jet Print Cartridge Designer's Guide (2nd Edition Hewlett Packard) (“Jet Print Cartridge Designers Guide”), 12 pgs. |
USPTO, Final Written Decision, U.S. Pat. No. 8,314,591, Nov. 15, 2021, pp. 1-42, Paper 21. |
Number | Date | Country | |
---|---|---|---|
20220323697 A1 | Oct 2022 | US |
Number | Date | Country | |
---|---|---|---|
61987005 | May 2014 | US | |
62000101 | May 2014 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16010932 | Jun 2018 | US |
Child | 17658210 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14701046 | Apr 2015 | US |
Child | 16010932 | US | |
Parent | 14279174 | May 2014 | US |
Child | 14701046 | US | |
Parent | 13698020 | Nov 2012 | US |
Child | 14279174 | US | |
Parent | 12780871 | May 2010 | US |
Child | 13698020 | US | |
Parent | 12780872 | May 2010 | US |
Child | 13698020 | US | |
Parent | 12780873 | May 2010 | US |
Child | 13698020 | US | |
Parent | 12780874 | May 2010 | US |
Child | 13698020 | US | |
Parent | 12780875 | May 2010 | US |
Child | 13698020 | US | |
Parent | 12780876 | May 2010 | US |
Child | 13698020 | US | |
Parent | 12780877 | May 2010 | US |
Child | 13698020 | US | |
Parent | 14285605 | May 2014 | US |
Child | 16010932 | Jun 2018 | US |
Parent | 12780873 | May 2010 | US |
Child | 14285605 | US | |
Parent | 14716204 | May 2015 | US |
Child | 16010932 | Jun 2018 | US |
Parent | 14275494 | May 2014 | US |
Child | 16010932 | Jun 2018 | US |
Parent | 12780875 | May 2010 | US |
Child | 14275494 | US |